Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Profile photo

Peter Rossing

Chief Consultant

  • Steno Diabetes Center Copenhagen
Visiting address:
Niels Steensens Vej 2-4
NSK
2820
Gentofte
Denmark

Email: peter.rossing@regionh.dk

Phone: 30913383

Main research areas

Diabetic nephropathy, cardiovascular disease, neuropathy, metabolomics

Employment

Chief Consultant

Steno Diabetes Center Copenhagen

The Capital Region of Denmark

Gentofte, Denmark

1 Jan 2017 → present

Steno Diabetes Center A/S

Gentofte, Denmark

… → 2016

Professor in endocrinology with focus on vascular complications

University of Copenhagen

Copenhagen, Capital Region of Denmark, Denmark

Publications

Relation of cardiac adipose tissue to coronary calcification and myocardial microvascular function in type 1 and type 2 diabetes

Zobel, E. H., Christensen, R. H., Winther, S. A., Hasbak, P., Hansen, C. S., von Scholten, B. J., Holmvang, L., Kjaer, A., Rossing, P. & Hansen, T. W., 10 Feb 2020, In : Cardiovascular Diabetology. 19, 1, 16.

Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial

DAPA-CKD Investigators , 7 Feb 2020, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 35, 2, p. 274-282 9 p.

Metformin and cardiorenal outcomes in diabetes: a reappraisal

Petrie, J. R., Rossing, P. & Campbell, I. W., 3 Feb 2020, In : Diabetes, Obesity and Metabolism.

Describing the fecal metabolome in cryogenically collected samples from healthy participants

Trošt, K., Ahonen, L., Suvitaival, T., Christiansen, N., Nielsen, T., Thiele, M., Jacobsen, S., Krag, A., Rossing, P., Hansen, T., Dragsted, L. O. & Legido-Quigley, C., 21 Jan 2020, In : Scientific Reports. 10, 885.

Carotid-femoral pulse wave velocity is a risk marker for complications in persons with type 1 diabetes

Tougaard, N. H., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, T. S., Hansen, T. W., Rossing, P. & Frimodt-Møller, M., 18 Jan 2020.

Changes in diabetes distress among people with type 2 diabetes during a risk screening programme for diabetic kidney disease - Longitudinal observations of the PRIORITY study

Joensen, L. E., Madsen, K. P., Frimodt-Møller, M., Tofte, N., Willaing, I., Lindhardt, M. & Rossing, P., 1 Jan 2020, In : Journal of Diabetes and its Complications. 34, 1, 107467.

Mitigating risk of aldosterone in diabetic kidney disease

Frimodt-Møller, M., Persson, F. & Rossing, P., 1 Jan 2020, In : Current opinion in nephrology and hypertension. 29, 1, p. 145-151 6 p.

2019 update to Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Buse, J. B., Wexler, D. J., Tsapas, A., Rossing, P., Mingrone, G., Mathieu, C., D'Alessio, D. A. & Davies, M. J., Jan 2020, In : Diabetologia. 63, p. 221-228

Metabolomic and Proteomic Techniques for Establishing Biomarkers and Improving Our Understanding of Pathophysiology in Diabetic Nephropathy

Siwy, J., Ahonen, L., Magalhães, P., Frantzi, M. & Rossing, P., 2020, Diabetic Nephropathy - Methods and Protocols. Gnudi, L. & Long, D. A. (eds.). Vol. 2067. p. 287-306 20 p. (Methods in molecular biology (Clifton, N.J.)).

Linking glycemic dysregulation in diabetes to symptoms, comorbidities, and genetics through EHR data mining

Kirk, I. K., Simon, C., Banasik, K., Holm, P. C., Haue, A. D., Jensen, P. B., Juhl Jensen, L., Rodríguez, C. L., Pedersen, M. K., Eriksson, R., Andersen, H. U., Almdal, T., Bork-Jensen, J., Grarup, N., Borch-Johnsen, K., Pedersen, O., Pociot, F., Hansen, T., Bergholdt, R., Rossing, P. & Brunak, S., 10 Dec 2019, In : eLife. 8, 19 p., e44941.

The effect of needle tenotomy on hammer, mallet and claw toe deformities in patients with diabetes, a retrospective study

Hedegaard Andersen, J., Rasmussen, A., Frimodt-Møller, M., Rossing, P., Kirketerp-Møller, K. & Engberg, S., 1 Dec 2019, In : Journal of Clinical and Translational Endocrinology. 18, 100208.

Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 Study

Jensen, M. T., Sogaard, P., Gustafsson, I., Bech, J., Hansen, T. F., Almdal, T., Theilade, S., Biering-Sørensen, T., Jørgensen, P. G., Galatius, S., Andersen, H. U. & Rossing, P., Dec 2019, In : Diabetologia. 62, 12, p. 2354-2364 11 p.

Response to Comment on Pilemann-Lyberg et al. Uric Acid Is an Independent Risk Factor for Decline in Kidney Function, Cardiovascular Events, and Mortality in Patients With Type 1 Diabetes.

Pilemann-Lyberg, S., Hansen, T. W. & Rossing, P., Dec 2019, In : Diabetes Care. 42, 12, p. e188

Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)

Jürgens, M., Schou, M., Hasbak, P., Kjær, A., Wolsk, E., Zerahn, B., Wiberg, M., Brandt, N. H., Gæde, P. H., Rossing, P., Faber, J., Inzucchi, S., Gustafsson, F. & Kistorp, C. M., 27 Nov 2019, In : BMJ Open. 9, 11, e029098.

Metabolomic assessment reveals alteration in polyols and branched chain amino acids associated with present and future renal impairment in a discovery cohort of 637 persons with type 1 diabetes

Tofte, N., Suvitaival, T., Trošt, K., Mattila, I., Theilade, S., Winther, S. A., Ahluwalia, T. S., Frimodt-Møller, M., Legido-Quigley, C. & Rossing, P., 22 Nov 2019, In : Frontiers in Endocrinology. 10, p. 1-11 11 p., 818.

Genome wide association study of apparent treatment resistant hypertension in the CHARGE consortium: The CHARGE Pharmacogenetics Working Group

VA Million Veteran Program and the CHARGE Pharmacogenetics Working group, 15 Nov 2019, In : American Journal of Hypertension. 32, 12, p. 1146-1153 8 p.

Major adverse renal events (MARE): A proposal to unifying renal endpoints

Prischl, F. C., Rossing, P., Bakris, G., Mayer, G. & Wanner, C., 11 Nov 2019, In : Nephrology Dialysis Transplantation.

Lipidomic analysis reveals sphingomyelin and phosphatidylcholine species associated with renal impairment and all-cause mortality in type 1 diabetes

Tofte, N., Suvitaival, T., Ahonen, L., Winther, S. A., Theilade, S., Frimodt-Møller, M., Ahluwalia, T. S. & Rossing, P., 8 Nov 2019, In : Scientific Reports. 9, 1, 10 p., 16398.

Effect of bardoxolone methyl on the urine albumin-to-creatinine ratio in patients with type 2 diabetes and stage 4 chronic kidney disease

Rossing, P., Block, G. A., Chin, M. P., Goldsberry, A., Heerspink, H. J. L., McCullough, P. A., Meyer, C. J., Packham, D., Pergola, P. E., Spinowitz, B., Sprague, S. M., Warnock, D. G. & Chertow, G. M., 1 Oct 2019, In : Kidney International. 96, 4, p. 1030-1036 7 p.

Genome-Wide Association Study of Diabetic Kidney Disease Highlights Biology Involved in Glomerular Basement Membrane Collagen

SUMMIT Consortium, DCCT/EDIC Research Group, GENIE Consortium, 1 Oct 2019, In : Journal of the American Society of Nephrology. 30, 10, p. 2000-2016 17 p.

Inflammation Leads the Way on the ROADMAP to Diabetic Kidney Disease

Persson, F., Frimodt-Møller, M. & Rossing, P., 1 Oct 2019, In : Kidney International Reports. 4, 10, p. 1362-1365 4 p.

Prognostic value of ratio of transmitral early filling velocity to early diastolic strain rate in patients with Type 2 diabetes

Lassen, M. C. H., Jensen, M. T., Biering-Sørensen, T., Møgelvang, R., Fritz-Hansen, T., Vilsbøll, T., Rossing, P. & Jørgensen, P. G., 1 Oct 2019, In : European heart journal cardiovascular Imaging. 20, 10, p. 1171-1178 8 p.

Progressive decline in estimated glomerular filtration rate in patients with diabetes after moderate loss in kidney function - even without albuminuria

Vistisen, D., Andersen, G. S., Hulman, A., Persson, F., Rossing, P. & Jørgensen, M. E., 1 Oct 2019, In : Diabetes Care. 42, 10, p. 1886-1894 9 p.

Assessment of the Sublingual Microcirculation with the GlycoCheck System: Reproducibility and Examination Conditions

Frimodt-Møller, M., Eickhoff, M. K., Winther, S. A., Diaz, L. J., Persson, F., Hansen, T. W. & Rossing, P., Oct 2019, In : Journal of the American Society of Nephrology. 30, p. 849 1 p., SA-PO331.

Hypoxia in individuals with type 1 diabetes and macroalbuminuria is associated with autonomic dysfunction

Laursen, J. C., Clemmensen, K. K. B., Hansen, C. S., Diaz, L. J., Groop, P-H., Frimodt-Møller, M., Bernardi, L. & Rossing, P., Oct 2019, In : Journal of the American Society of Nephrology. 30, p. 361 1 p., TH-PO92.

Impact of binge drinking on hepatic lipid metabolism: lipidome analysis of liver vein and peripheral blood during acute alcohol intoxication

Bastrup Israelsen, M., Trošt, K., Stæhr Madsen, B., Suvitaival, T., Hansen, C., Thiele, M., Rossing, P., Hansen, T., Legido-Quigley, C. & Krag, A., Oct 2019, In : Hepatology. 70, Suppl 1, p. 172-173 1 p., 267.

Individual Effects of Liraglutide on Cardiorenal Risk Markers: Results from the LEADER Trial

Persson, F., Zobel, E. H., Hansen, T., Rasmussen, S., Von Scholten, B. J., Wolthers, B. & Rossing, P., Oct 2019, In : Journal of the American Society of Nephrology. 30, p. 1096 1 p., PUB071.

Lipoprotein(a) and Decline in Renal Function, Incidence of Cardiovascular Disease, and Mortality in Individuals with Type 2 Diabetes and Microalbuminuria

S. Heinrich, N., von Scholten, B. J., Persson, F., Hansen, T., Parving, H-H. & Rossing, P., Oct 2019, In : Journal of the American Society of Nephrology. 30, p. 1094 1 p., PUB081.

Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy

Tofte, N., Lindhardt, M. K., Currie, G., Frimodt-Møller, M., von der Leyen, H., Delles, C., Mischak, H. & Rossing, P., Oct 2019, In : Journal of the American Society of Nephrology. 30, p. 1 72 p., FR-OR113 .

Polyols and Branched Chained Amino Acids Are Associated with Present and Future Renal Impairment in Type 1 Diabetes

Tofte, N., Suvitaival, T., Trošt, K., Mattila, I., Theilade, S., Winther, S. A., Ahluwalia, T. S., Frimodt-Møller, M., Legido-Quigley, C. & Rossing, P., Oct 2019, In : Journal of the American Society of Nephrology. 30, p. 362 1 p., TH-PO934.

Relative hypoxia in supine and standing position in type 1 diabetes: Impaired autonomic cardiorespiratory control around the clock?

Laursen, J. C., Hansen, C. S., Bordino, M., Zobel, E. H., Winther, S. A., Groop, P-H., Frimodt-Møller, M., Bernardi, L. & Rossing, P., Oct 2019. 1 p.

Spironolactone for the prevention of microalbuminuria in high risk type 2 diabetes: Results from the multicenter randomized double-blind controlled study "PRIORITY"

Lindhardt, M. K., Tofte, N., Frimodt-Møller, M., Currie, G., Delles, C., von der Leyen, H., Mischak, H. & Rossing, P., Oct 2019, In : Journal of the American Society of Nephrology. 30, p. 498 1 p., FR-PO247.

The association between vitamin D level and microvascular complications in persons with type 2 diabetes

Tougaard, N. H., Hansen, T. W. & Rossing, P., Oct 2019, In : Journal of the American Society of Nephrology. 30, p. 905 1 p., SA-PO557.

Trimethylamine-N-Oxide and Renal Complications, Cardiovascular Disease, and Mortality in Individuals with Type 2 Diabetes and Microalbuminuria

Winther, S. A., Øllgaard, J. C., Hansen, T. W., Von Scholten, B. J., Gæde, P., Parving, H-H., Pedersen, O. & Rossing, P., Oct 2019, In : Journal of the American Society of Nephrology. 30, p. 904 1 p., SA-PO551.

Urinary Glycolic Acid Predicts Kidney Function Decline in Type 1 Diabetic Subjects

Darshi, M., Kim, J. J., Ahluwalia, T. S., Rossing, P., Groop, P-H. & Sharma, K., Oct 2019, In : Journal of the American Society of Nephrology. 30, p. 358 1 p., TH-PO919.

Visit-to-Visit Variability of Albuminuria and eGFR as Risk Markers for Renal Complications, Cardiovascular Events, and Mortality in Type 1 Diabetes

Curovic, V. R., Theilade, S., Winther, S. A., Tofte, N., Jorsal, A., Parving, H-H., Persson, F., Hansen, T. & Rossing, P., Oct 2019, In : Journal of the American Society of Nephrology. 30, p. 904 1 p., SA-PO552.

Editorial: Novel Biomarkers for Type 2 Diabetes

Ahluwalia, T. S., Kilpeläinen, T. O., Singh, S. & Rossing, P., 27 Sep 2019, In : Frontiers in Endocrinology. 10, 649.

Association of Birth Weight With Type 2 Diabetes and Glycemic Traits: A Mendelian Randomization Study

BIRTH-GENE (BIG) Study Working Group, 20 Sep 2019, In : JAMA network open. 2, 9, 18 p., e1910915.

Targeted Clinical Metabolite Profiling Platform for the Stratification of Diabetic Patients

Ahonen, L., Jäntti, S., Suvitaival, T., Theilade, S., Risz, C., Kostiainen, R., Rossing, P., Orešič, M. & Hyötyläinen, T., 14 Sep 2019, In : Metabolites. 9, 9, 184.

Beneficial impact of intensified multifactorial intervention on risk of stroke: outcome of 21 years of follow-up in the randomised Steno-2 Study

Gæde, P., Oellgaard, J., Kruuse, C., Rossing, P., Parving, H-H. & Pedersen, O., 1 Sep 2019, In : Diabetologia. 62, 9, p. 1575-1580 6 p.

Cell populations and molecular biomarkers in blood and urine characterise nephropathy in type 1 diabetes

Henriksen, P., Kyluik-Price, D., Winther, S. A., Suvitaival, T., Legido-Quigley, C., Timmermann, D. B. & Rossing, P., 1 Sep 2019, In : Diabetologia. 62, Suppl 1, p. 478 1 p., 986.

Markers of Collagen Formation and Degradation Reflect Renal Function and Predict Adverse Outcomes in Patients With Type 1 Diabetes

Pilemann-Lyberg, S., Rasmussen, D. G. K., Hansen, T. W., Tofte, N., Winther, S. A., Nielsen, S. H., Theilade, S., Karsdal, M. A., Genovese, F. & Rossing, P., 1 Sep 2019, In : Diabetes Care. 42, 9, p. 1760-1768 9 p.

Circulating metabolites are associated with present and future renal impairment in type 1 Diabetes

Tofte, N., Suvitaival, T., Trošt, K., Mattila, I., Theilade, S., Winther, S. A., Ahluwalia, T. S., Frimodt-Møller, M., Legido-Quigley, C. & Rossing, P., Sep 2019, In : Diabetologia. 62, Suppl 1, p. 30 1 p., 57.

Dapagliflozin improves the urinary CKD273 proteomic score when added to renin-angiotensin blockade in patients with type 2 diabetes and nephropathy

Eickhoff, M. K., Frimodt-Møller, M., Mischak, H., Rossing, P. & Persson, F., Sep 2019, In : Diabetologia. 62, Suppl 1, p. 40 1 p., 77.

Estimated GFR (eGFR) loss with glucagon like peptide 1 (GLP1) analogue treatment: Data from Sustain 6 and LEADER

Perkovic, V., Bain, S. C., Bakris, G. L., Buse, J. B., Gondolf, T., Idorn, T., Lausvig, N., Mahaffey, K. W., Marso, S. P., Nauck, M. A., Pratley, R. E., Rossing, P., Zinman, B. & Mann, J. F. E., Sep 2019, In : Diabetologia. 62, Suppl 1, p. 484 1 p., 998.

Plasma metabolomics identifies markers of kidney function in 3,064 Europeans with type 2 diabetes

Ahluwalia, T. S., Tofte, N., Vogelzangs, N., Mook-Kanamori, D., Brahimaj, A., Frimodt-Møller, M., Arts, I., Beulens, J., van der Heijden, A., Stehouwer, C., Nijpels, G., van Greevenbroek, M., van der Kallen, C., Rossing, P. & t' Hart, L. M., Sep 2019, In : Diabetologia. 62, Suppl 1, p. 456 1 p., 937.

Relative hypoxia in supine and standing position in type 1 diabetes: Impaired autonomic cardiorespiratory control around the clock?

Laursen, J. C., Hansen, C. S., Bordino, M., Zobel, E. H., Winther, S. A., Groop, P-H., Frimodt-Møller, M., Bernardi, L. & Rossing, P., Sep 2019. 1 p.

Relative hypoxia in supine and standing position in type 1 diabetes: Impaired autonomic cardiorespiratory control around the clock?

Laursen, J. C., Hansen, C. S., Bordino, M., Zobel, E. H., Winther, S. A., Groop, P-H., Frimodt-Møller, M., Bernardi, L. & Rossing, P., Sep 2019, In : Diabetologia. 62, Suppl 1, p. 52 1 p., 98.

Renal function dominates the landscape of the metabolome in type 1 diabetes

Suvitaival, T., Tofte, N., Mattila, I., Trošt, K., Theilade, S., Winther, S. A., Ahluwalia, T. S., Frimodt-Møller, M., Rossing, P. & Legido-Quigley, C., Sep 2019, In : Diabetologia. 62, Suppl 1, p. 455 1 p., 936.

Role of gastrointestinal inflammation in diabetic kidney disease

Mannerla, M., Winther, S. A., Frimodt-Møller, M., Persson, F., Hansen, T. W., Forsblom, C., Lehto, M., Groop, P-H. & Rossing, P., Sep 2019, In : Diabetologia. 62, Suppl 1, p. 480 1 p., 991.

The utility of plasma concentration of Trimethylamine-N-Oxide in predicting cardiovascular and renal complications in individuals with type 1 diabetes

Winther, S. A., Øllgaard, J. C., Tofte, N., Tarnow, L., Wang, Z., Ahluwalia, T. S., Jorsal, A., Theilade, S., Parving, H. H., Hansen, T., Hazen, S. L., Pedersen, O. & Rossing, P., Sep 2019, In : Diabetologia. 62, Suppl 1, p. 32 1 p., 60.

Visit-to-visit variability of HbA1c and systolic BP as risk markers for cardiovascular events, end stage renal disease, renal function decline and mortality in type 1 diabetes

Curovic, V. R., Theilade, S., Winther, S. A., Tofte, N., Tarnow, L., Jorsal, A., Parving, H. H., Persson, F., Hansen, T. W. & Rossing, P., Sep 2019, In : Diabetologia. 62, Suppl 1, p. 568 1 p., 1181.

Epicardial adipose tissue predicts incident cardiovascular disease and mortality in patients with type 2 diabetes

Christensen, R. H., von Scholten, B. J., Hansen, C. S., Jensen, M. T., Vilsbøll, T., Rossing, P. & Jørgensen, P. G., 30 Aug 2019, In : Cardiovascular Diabetology. 18, 1, 114.

An echocardiographic substrate for dyspnea identifies high risk patients with type 2 diabetes

Jørgensen, P. G., Schou, M., Biering-Sørensen, T., Mogelvang, R., Fritz-Hansen, T., Vilsbøll, T., Rossing, P. & Jensen, M. T., 15 Aug 2019, In : International Journal of Cardiology. 289, p. 119-124 6 p.

Epicardial and pericardial adipose tissues are associated with reduced diastolic and systolic function in type 2 diabetes

Christensen, R. H., Hansen, C. S., von Scholten, B. J., Jensen, M. T., Pedersen, B. K., Schnohr, P., Vilsbøll, T., Rossing, P. & Jørgensen, P. G., 1 Aug 2019, In : Diabetes, Obesity and Metabolism. 21, 8, p. 2006-2011 6 p.

Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol-Rationale, Design, and Baseline Data

PERL Study Group, 1 Aug 2019, In : Diabetes Care. 42, 8, p. 1454-1463 10 p.

Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes

Winther, S. A., Øllgaard, J. C., Tofte, N., Tarnow, L., Wang, Z., Ahluwalia, T. S., Jorsal, A., Theilade, S., Parving, H-H., Hansen, T. W., Hazen, S. L., Pedersen, O. & Rossing, P., Aug 2019, In : Diabetes Care. 42, 8, p. 1512-1520 9 p.

Efficacy of Long-Term Remote Ischemic Conditioning on Vascular and Neuronal Function in Type 2 Diabetes Patients With Peripheral Arterial Disease

Hansen, C. S., Jørgensen, M. E., Fleischer, J., Bøtker, H. E. & Rossing, P., 2 Jul 2019, In : Journal of the American Heart Association. 8, 13, p. 1-17 17 p., e011779.

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

PIONEER 5 Investigators, 1 Jul 2019, In : The Lancet Diabetes and Endocrinology. 7, 7, p. 515-527 13 p.

Myocardial flow reserve assessed by cardiac 82Rb positron emission tomography/computed tomography is associated with albumin excretion in patients with Type 1 diabetes

Zobel, E. H., Winther, S. A., Hasbak, P., von Scholten, B. J., Holmvang, L., Kjaer, A., Rossing, P. & Hansen, T. W., 1 Jul 2019, In : European heart journal cardiovascular Imaging. 20, 7, p. 796-803 8 p., jey174.

A catalog of genetic loci associated with kidney function from analyses of a million individuals

LifeLines Cohort study, 1 Jun 2019, In : Nature Genetics. 51, 6, p. 957-972 16 p.

Albuminuria-lowering effect of dapagliflozin alone and in combination with saxagliptin and effect of dapagliflozin and saxagliptin on glycaemic control in patients with type 2 diabetes and chronic kidney disease (DELIGHT): a randomised, double-blind, placebo-controlled trial

Pollock, C., Stefánsson, B., Reyner, D., Rossing, P., Sjöström, C. D., Wheeler, D. C., Langkilde, A. M. & Heerspink, H. J. L., 1 Jun 2019, In : The Lancet Diabetes and Endocrinology. 7, 6, p. 429-441 13 p.

Cardiac Autonomic Function is Associated With Myocardial Flow Reserve in Type 1 Diabetes

Zobel, E. H., Hasbak, P., Winther, S. A., Stevns, C., Fleischer, J., von Scholten, B. J., Holmvang, L., Kjaer, A., Rossing, P. & Hansen, T. W., 1 Jun 2019, In : Diabetes. 68, 6, p. 1277-1286 10 p.

Improvements in albuminuria and chronic kidney disease progression with the appetite suppressant lorcaserin

Rossing, P., Persson, F. & Frimodt-Møller, M., 1 Jun 2019, In : Kidney International. 95, 6, p. 1287-1288 2 p.

Soluble Urokinase Plasminogen Activator Receptor Predicts Cardiovascular Events, Kidney Function Decline, and Mortality in Patients With Type 1 Diabetes

Rotbain Curovic, V., Theilade, S., Winther, S. A., Tofte, N., Eugen-Olsen, J., Persson, F., Hansen, T. W., Jeppesen, J. & Rossing, P., 1 Jun 2019, In : Diabetes Care. 42, 6, p. 1112-1119 8 p.

Uric acid is an independent risk factor for decline in kidney function, cardiovascular events, and mortality in patients with type 1 diabetes

Pilemann-Lyberg, S., Hansen, T. W., Tofte, N., Winther, S. A., Theilade, S., Ahluwalia, T. S. & Rossing, P., 1 Jun 2019, In : Diabetes Care. 42, 6, p. 1088-1094 7 p.

A marker of type VI collagen formation (PRO-C6) is associated with higher arterial stiffness in type 1 diabetes

Frimodt-Møller, M., Hansen, T. W., Rasmussen, D. G. K., Theilade, S., Nielsen, S. H., Karsdal, M. A., Genovese, F. & Rossing, P., Jun 2019, In : Acta Diabetologica. 56, 6, p. 711-712 2 p.

Dapagliflozin improves the urinary CKD273 proteomic score when added to renin-angiotensin blockade in patients with type 2 diabetes and nephropathy

Eickhoff, M. K., Frimodt-Møller, M., Mischak, H., Rossing, P. & Persson, F., Jun 2019, In : Diabetes. 68, Suppl 1, 1 p., 526-P.

Effects of semaglutide and liraglutide on urinary albumin-to-creatinine ration (UACR) -A pooled analysis of sustain 6 and leader

Perkovic, V., Bain, S. C., Bakris, G. L., Buse, J. B., Idorn, T., Mahaffey, K. W., Marso, S. P., Nauck, M. A., Pratley, R. E., Rasmussen, S., Rossing, P., Tornøe, K., Zinman, B. & Mann, J., Jun 2019, In : Nephrology Dialysis Transplantation. 34, Suppl 1, p. 205 FP483.

Effects of the glucogon-like peptide-1 (GLP-1) analogues semaglutide and liragutide on renal outcomes - A pooled analysis of the sustain 6 and leader trials

Perkovic, V., Bain, S. C., Bakris, G. L., Buse, J. B., Idorn, T., Mahaffey, K. W., Marso, S. P., Nauck, M. A., Pratley, R. E., Rasmussen, S., Rossing, P., Tornøe, K., Zinman, B. & Mann, J., Jun 2019, In : Nephrology Dialysis Transplantation. 34, Suppl 1, p. 388 SaO010.

EGFR loss with glucagon-like-peptide-1 (GLP-1) analouge treatment: Data from sustain 6 and leader

Perkovic, V., Bain, S. C., Bakris, G. L., Buse, J. B., Gondolf, T., Idorn, T., Lausvig, N., Mahaffey, K. W., Marso, S. P., Nauck, M. A., Pratley, R. E., Rossing, P., Zinman, B. & Mann, J., Jun 2019, In : Nephrology Dialysis Transplantation. 34, Suppl 1, FP482 .

Obesity remains a major risk factor associated with vascular stiffening in type 2 diabetes

Currie, G., Flynn, J., Rossing, P. & Delles, C., Jun 2019, In : Journal of Hypertension. 37, Suppl 1, p. 65

Predictive value of echocardiography in Type 2 diabetes

Jørgensen, P. G., Biering-Sørensen, T., Mogelvang, R., Fritz-Hansen, T., Vilsbøll, T., Rossing, P. & Jensen, M. T., Jun 2019, In : European heart journal cardiovascular Imaging. 20, 6, p. 687-693 7 p.

Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System Inhibitors

Eickhoff, M. K., Dekkers, C. C. J., Kramers, B. J., Laverman, G. D., Frimodt-Møller, M., Jørgensen, N. R., Faber, J., Danser, A. H. J., Gansevoort, R. T., Rossing, P., Persson, F. & Heerspink, H. J. L., 31 May 2019, In : Journal of Clinical Medicine. 8, 6

Dapagliflozin improves the urinary CKD273 proteomic score when added to renin-angiotensin blockade in patients with type 2 diabetes and nephropathy

Eickhoff, M. K., Frimodt-Møller, M., Mischak, H., Rossing, P. & Persson, F., 24 May 2019.

Identification of serum metabolites associated with renal impairment: A metabolomics study in Type 1 Diabetes

Tofte, N., Suvitaival, T., Trošt, K., Mattila, I., Theilade, S., Winther, S. A., Ahluwalia, T. S., Frimodt-Møller, M., Legido-Quigley, C. & Rossing, P., 24 May 2019.

Pulse Wave Velocity is an Independent Risk Factor for Cardiovascular Events, Mortality and Decline in Renal Function in Patients with Type 1 Diabetes

Hansen, T. W., Frimodt-Møller, M., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, T. S. & Rossing, P., 24 May 2019.

Soluble urokinase plasminogen activator receptor predicts cardiovascular events, kidney function decline, and mortality in patients with type 1 diabetes

Curovic, V. R., Theilade, S., Winther, S. A., Tofte, N., Eugen-Olsen, J., Persson, F., Hansen, T. W., Jeppesen, J. & Rossing, P., 24 May 2019.

The utility of plasma concentration of Trimethylamine-N-Oxide in predicting cardiovascular and renal complications in individuals with type 1 diabetes

Winther, S. A., Øllgaard, J. C., Tofte, N., Tarnow, L., Wang, Z., Ahluwalia, T. S., Jorsal, A., Theilade, S., Parving, H-H. D., Hansen, T. W., Hazen, S. L., Pedersen, O. & Rossing, P., 24 May 2019.

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

SONAR Committees and Investigators, 11 May 2019, In : The Lancet. 393, 10184, p. 1937-1947 11 p.

Cardiac ventricular sizes are reduced in patients with long-term, normoalbuminuric type 1 diabetes compared to the non-diabetic background population

Hjortkjær, H. Ø., Jensen, T., Hilsted, J., Mogensen, U. M., Corinth, H., Rossing, P., Sigvardsen, P. E., Fuchs, A., Kühl, J. T., Nordestgaard, B. G., Køber, L. & Kofoed, K. F., 1 May 2019, In : Diabetes and Vascular Disease Research. 16, 3, p. 289-296 8 p.

Correction to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Davies, M. J., D'Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J. & Buse, J. B., May 2019, In : Diabetologia. 62, 5, p. 873 1 p.

MR-proANP effectively risk stratifies patients with type 2 diabetes regardless of presence of heart failure

Jensen, J., Schou, M., Kistorp, C., Faber, J., Hansen, T. W., M T, J., Andersen, H. U., Rossing, P., Vilsbøll, T. & Jørgensen, P. G., May 2019, In : European Journal of Heart Failure. 21, Suppl 1, p. 223 P964.

Pleiotropic effects of liraglutide in patients with type 2 diabetes and moderate renal impairment: individual effects of treatment

Zobel, E. H., von Scholten, B. J., Goldman, B., Persson, F., Hansen, T. W. & Rossing, P., May 2019, In : Diabetes, Obesity and Metabolism. 21, 5, p. 1261-1265 5 p.

Increasing ESKD in Diabetes in the Land Down Under: What Can Be Done, We Must Wonder

Rossing, P., Frimodt-Møller, M. & Persson, F., 1 Mar 2019, In : American journal of kidney diseases : the official journal of the National Kidney Foundation. 73, 3, p. 293-296 4 p.

Reduction in Albuminuria With Dapagliflozin Cannot Be Predicted by Baseline Clinical Characteristics or Changes in Most Other Risk Markers

Heerspink, H. J. L., Sjöström, C. D., Inzucchi, S. E., Hallow, M. K., Cain, V. A., Rossing, P., Stefansson, B. V. & Sartipy, P., 1 Mar 2019, In : Diabetes, Obesity and Metabolism. 21, 3, p. 720-725 6 p.

Prevalence of heart failure and the diagnostic value of MR-proANP in outpatients with type 2 diabetes

Jensen, J., Schou, M., Kistorp, C., Faber, J., Hansen, T. W., Jensen, M. T., Andersen, H. U., Rossing, P., Vilsbøll, T. & Jørgensen, P. G., Mar 2019, In : Diabetes, Obesity and Metabolism. 21, 3, p. 736-740 5 p.

Urinary proteomics and precision medicine for chronic kidney disease: Current status and future perspectives

Persson, F. & Rossing, P., Mar 2019, In : Proteomics - Clinical Applications. 13, 2, 1800176.

A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuria

Ahluwalia, T. S., Schulz, C-A., Waage, J., Skaaby, T., Sandholm, N., van Zuydam, N., Charmet, R., Bork-Jensen, J., Almgren, P., Thuesen, B. H., Bedin, M., Brandslund, I., Christensen, C. K., Linneberg, A., Ahlqvist, E., Groop, P-H., Hadjadj, S., Tregouet, D-A., Jørgensen, M. E., Grarup, N., Pedersen, O., Simons, M., Groop, L., Orho-Melander, M., McCarthy, M. I., Melander, O., Rossing, P., Kilpeläinen, T. O. & Hansen, T., 1 Feb 2019, In : Diabetologia. 62, 2, p. 292-305 14 p.

Left ventricular remodelling and cardiac chamber sizes in long-term, normoalbuminuric type 1 diabetes patients with and without cardiovascular autonomic neuropathy

Hjortkjær, H. Ø., Jensen, T., Hilsted, J., Mogensen, U. M., Corinth, H., Rossing, P., Køber, L. & Kofoed, K. F., 1 Feb 2019, In : Journal of Diabetes and its Complications. 33, 2, p. 171-177 7 p.

Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy

Skupien, J., Smiles, A. M., Valo, E., Ahluwalia, T. S., Gyorgy, B., Sandholm, N., Croall, S., Lajer, M., McDonnell, K., Forsblom, C., Harjutsalo, V., Marre, M., Galecki, A. T., Tregouet, D-A., Wu, C. Y., Mychaleckyj, J. C., Nickerson, H., Pragnell, M., Rich, S. S., Pezzolesi, M. G., Hadjadj, S., Rossing, P., Groop, P-H. & Krolewski, A. S., 1 Jan 2019, In : Diabetes Care. 42, 1, p. 93-101 9 p.

Generalised arterial calcification in normoalbuminuric patients with type 1 diabetes with and without cardiovascular autonomic neuropathy

Hjortkjær, H. Ø., Jensen, T., Hilsted, J., Mogensen, U. M., Rossing, P., Køber, L. & Kofoed, K. F., Jan 2019, In : Diabetes and Vascular Disease Research. 16, 1, p. 98-102 5 p.

Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries

Eder, S., Leierer, J., Kerschbaum, J., Rosivall, L., Wiecek, A., de Zeeuw, D., Mark, P. B., Heinze, G., Rossing, P., Heerspink, H. L. & Mayer, G., Jan 2019, In : Diabetes and Vascular Disease Research. 16, 1, p. 47-56 10 p.

Application of urinary proteomics as possible risk predictor of renal and cardiovascular complications in patients with type 2-diabetes and microalbuminuria

Oellgaard, J., Gæde, P., Persson, F., Rossing, P., Parving, H-H. & Pedersen, O., 1 Dec 2018, In : Journal of Diabetes and its Complications. 32, 12, p. 1133-1140 8 p.

Effects of bardoxolone methyl on body weight, waist circumference and glycemic control in obese patients with type 2 diabetes mellitus and stage 4 chronic kidney disease

Chertow, G. M., Appel, G. B., Block, G. A., Chin, M. P., Coyne, D. W., Goldsberry, A., Kalantar-Zadeh, K., Meyer, C. J., Molitch, M. E., Pergola, P. E., Raskin, P., Silva, A. L., Spinowitz, B., Sprague, S. M. & Rossing, P., 1 Dec 2018, In : Journal of Diabetes and its Complications. 32, 12, p. 1113-1117 5 p.

Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial

de Zeeuw, D., Renfurm, R. W., Bakris, G., Rossing, P., Perkovic, V., Hou, F. F., Nangaku, M., Sharma, K., Heerspink, H. J. L., Garcia-Hernandez, A. & Larsson, T. E., 1 Dec 2018, In : The Lancet Diabetes and Endocrinology. 6, 12, p. 925-933 8 p.

Urinary proteomics for prediction of mortality in patients with type 2 diabetes and microalbuminuria

Currie, G. E., von Scholten, B. J., Mary, S., Flores Guerrero, J-L., Lindhardt, M., Reinhard, H., Jacobsen, P. K., Mullen, W., Parving, H-H., Mischak, H., Rossing, P. & Delles, C., 1 Dec 2018, In : Cardiovascular Diabetology. 17, 50, p. 50 8 p.

Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Davies, M. J., D'Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J. & Buse, J. B., Dec 2018, In : Diabetologia. 61, 12, p. 2461-2498 37 p.

Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

Davies, M. J., D'Alessio, D. A., Fradkin, J., Kernan, W. N., Mathieu, C., Mingrone, G., Rossing, P., Tsapas, A., Wexler, D. J. & Buse, J. B., Dec 2018, In : Diabetes Care. 41, 12, p. 2669-2701 32 p.

Type 1 diabetes is associated with T-wave morphology changes. The Thousand & 1 Study

Isaksen, J. L., Graff, C., Ellervik, C., Jensen, J. S., Andersen, H. U., Rossing, P., Kanters, J. K. & Jensen, M. T., 1 Nov 2018, In : Journal of Electrocardiology. 51, 6, p. 72-77 6 p.

Cardiovascular autonomic neuropathy and bone metabolism in Type 1 diabetes

Hansen, C. S., Theilade, S., Lajer, M., Hansen, T. W. & Rossing, P., Nov 2018, In : Diabetic Medicine. 35, 11, p. 1596-1604 8 p.

Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patients

Rotbain Curovic, V., Hansen, T. W., Eickhoff, M. K., von Scholten, B. J., Reinhard, H., Jacobsen, P. K., Persson, F., Parving, H-H. & Rossing, P., Nov 2018, In : Acta Diabetologica. 55, 11, p. 1143-1150 7 p.

Acute Hyperoxia and Slow Deep Breathing Improve Baroreflex Sensitivity in Long-Duration Type 1 Diabetes Irrespective of Macroalbuminuria

Laursen, J. C., Hansen, C. S., Bordino, M., Zobel, E. H., Winther, S. A., Groop, P-H., Frimodt-Møller, M. & Rossing, P., 27 Oct 2018, In : Journal of the American Society of Nephrology. 29, p. 776 1 p., SA-PO158.

Effect of Dapagliflozin on Cardiac Function and Biomarkers in Patients with Type 2 Diabetes and Albuminuria – A Randomized Study

Eickhoff, M. K., Olsen, F. J., Frimodt-Møller, M., Diaz, L. J., Faber, J. O., Jensen, M. T., Rossing, P. & Persson, F., 27 Oct 2018, In : Journal of the American Society of Nephrology. p. 770 1 p., SA-PO139.

Plasma Metabolomics Profiling in Auto-Antibody-Positive Individuals Progressing to Type 1 Diabetes

Suvitaival, T., Wesley, J. D., Ali, A., Trošt, K., Ahonen, L. L., Overgaard, A. J., Mattila, I., Hagopian, W., von Herrath, M., Rossing, P., Pociot, F. & Legido-Quigley, C., 27 Oct 2018.

Reduction in Albuminuria with Dapagliflozin Cannot Be Predicted by Baseline Clinical Characteristics or Changes in Most Other Risk Markers

Lambers Heerspink, H. J., Sjöström, D., Inzucchi, S. E., Hallow, M. K., Cain, V. A., Rossing, P., Stefansson, B. V. & Sartipy, P., 27 Oct 2018, In : Journal of the American Society of Nephrology. SA-OR081.

Cathepsin D: A Potential Biomarker for Diabetic Kidney Disease

Drel, V., Natarajan, L., Hoofnagle, A., De Boer, I., Darshi, M., Sharma, K., Vaisar, T., Kim, J., Valo, E., Zhang, J., Ahluwalia, T. S., Snell-Bergeon, J., Rossing, P. & Groop, P-H., 26 Oct 2018, In : Journal of the American Society of Nephrology.

Exome Wide Association Study Identifies a Rare Coding Variant in Cubilin Gene and Suggestive Variants in Additional Genes Associated with Albuminuria Among 33,985 Europeans with and Without Diabetes

Ahluwalia, T. S., Bredslund, I., Christensen, C. K., Linneberg, A., Ahlqvist, E., Groop, P-H., Hadjadj, S., Groop, L., Grarup, N., Orho-Melander, M., McCarthy, M. I., Schulz, C-A., Melander, O., Rossing, P., Kilpelainen, T. O., Hansen, T., Skaaby, T., Sandholm, N., Bork-Jensen, J., van Zuydam, N. R., Almgren, P., Thuesen, B. H. & Jørgensen, M. E., 26 Oct 2018, In : Journal of the American Society of Nephrology. FR-PO431.

Increasing Baseline Albuminuria Is Associated with a Continuously Increased Risk of Cardiovascular (CV) and Renal Outcomes in the LEADER Trial

mosenzon, O., Raz, I., Bain, S. C., Persson, F., Lambers Heerspink, H. J., Mann, J., Rossing, P., Idorn, T., Rasmussen, S. & von Scholten, B. J., 26 Oct 2018, In : Journal of the American Society of Nephrology.

Myocardial Flow Reserve Assessed by Cardiac 82Rb PET/CT Is Associated with Albumin Excretion in Patients with Type 1 Diabetes

Zobel, E. H., Winther, S. A., Von Scholten, B. J., Holmvang, L., Kjær, A., Rossing, P. & Hansen, T. W., 26 Oct 2018, In : Journal of the American Society of Nephrology. FR-PO429.

Plasma lipids are associated with diabetic kidney disease: a study of plasma lipidomics in type 1 diabetes

Tofte, N., Suvitaival, T., Ahonen, L. L., Theilade, S., Winther, S. A., Frimodt-Møller, M., Ahluwalia, T. S. & Rossing, P., 26 Oct 2018, In : Journal of the American Society of Nephrology. 29, p. 535 1 p., FR-PO445.

Plasma metabolomics identifies markers of impaired kidney function: A meta-analyses of 1,984 Europeans with type 2 diabetes

Tofte, N., Ahluwalia, T. S., Vogelzangs, N., Mook-Kanamori, D., Brahimaj, A., Nano, J., van Dijk, K. W., Frimodt-Møller, M., van der Kallen, C., Arts, I., Beulens, J., van der Heijden, A., Nijpels, G., van Greevenbroek, M., Stehouwer, C., Rossing, P. & t' Hart, L. M., 26 Oct 2018, In : Journal of the American Society of Nephrology. 29, p. 535 1 p., FR-PO446.

Pulse Wave Velocity Is an Independent Risk Factor for Cardiovascular Events, Mortality and Decline in Renal Function in Patients with Type 1 Diabetes

Frimodt-Møller, M., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, T. S. & Rossing, P., 26 Oct 2018, In : Journal of the American Society of Nephrology. 29, 1, FR-PO430.

Soluble Urokinase Plasminogen Activator Receptor Predicts Kidney Function Decline and Mortality in Patients with Type 1 Diabetes

Rotbain Curovic, V., Theilade, S., Winther, S. A., Tofte, N., Eugen-Olsen, J., Persson, F., Hansen, T. W., Jeppesen, J. L. & Rossing, P., 26 Oct 2018, In : Journal of the American Society of Nephrology. 29, p. 537 1 p., FR-PO453.

Uric acid is an independent risk factor for mortality, cardiovascular event and decline in kidney function in patients with type 1 diabetes

Pilemann-Lyberg, S., Hansen, T. W., Tofte, N., Winther, S. A., Theilade, S., Ahluwalia, T. S. & Rossing, P., 26 Oct 2018, In : Journal of the American Society of Nephrology. 29, p. 537 1 p., FR-PO454.

Urine Metabolites Predict Kidney Function Decline in Type I Diabetic Subjects

Darshi, M., Groop, P-H., Natarajan, L., Sharma, K., Valo, E., Zhang, J., Kim, J. J., Saito, R., Montemayor, D., Ahluwalia, T. S., Snell-Bergeon, J. K. & Rossing, P., 26 Oct 2018, In : Journal of the American Society of Nephrology. FR-PO459.

Reduction in Albuminuria Is Associated with Cardiorenal Protection Independent of Baseline Albuminuria – A Post-Hoc Analysis of the LEADER Trial

Persson, F., Rossing, P., Bain, S. C., mosenzon, O., lambers heerspink, H., Mann, J., Raz, I., Idorn, T., Rasmussnén, S. & von Scholten, B. J., 25 Oct 2018, In : Journal of the American Society of Nephrology. 29, p. 9 1 p., TH-OR034.

Pulse Wave Velocity is an Independent Risk Factor for Cardiovascular Events, Mortality and Decline in Renal Function in Patients with Type 1 Diabetes

Hansen, T. W., Frimodt-Møller, M., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, T. S. & Rossing, P., 19 Oct 2018.

Effect of dapagliflozin on renal and cardiac function in patients with type 2 diabetes and albuminuria: a randomised study

Eickhoff, M. K., Olsen, F. J., Frimodt-Møller, M., Diaz, L. J., Jensen, M. T., Rossing, P. & Persson, F., 4 Oct 2018, In : Diabetologia. 61, Suppl 1, p. S299-S300 1 p., 619.

Pulse Wave Velocity is an Independent Risk Factor for Cardiovascular Events, Mortality and progression in diabetic kidney disease in patients with type 1 diabetes

Hansen, T. W., Frimodt-Møller, M., Theilade, S., Winther, S. A., Tofte, N., Ahluwalia, T. S. & Rossing, P., 4 Oct 2018, In : Diabetologia. 61, Suppl 1, p. S548-S548 1 p., 1123.

The REMOVAL Trial: Metformin reduces progression of carotid intima media thickness in never smokers with type 1 diabetes

Petrie, J. R., Chaturvedi, N., Ford, I., Rossing, P. & Colhoun, H. M., 4 Oct 2018, In : Diabetologia. 61, Suppl1, p. S555 1 p., 1138.

Trajectories of estimated GFR in patients with and without albuminuria

Jørgensen, M. E., Vistisen, D., Andersen, G. S., Hulman, A., Persson, F. & Rossing, P., 4 Oct 2018, In : Diabetologia. 61, Suppl1, p. S92 1 p., 181.

Burden of Uncontrolled Metabolic Risk Factors and Left Ventricular Structure and Function in Patients With Type 2 Diabetes Mellitus

Jørgensen, P. G., Jensen, M. T., Biering-Sørensen, T., Mogelvang, R., Fritz-Hansen, T., Vilsbøll, T., Rossing, P. & Jensen, J. S., 2 Oct 2018, In : Journal of the American Heart Association. 7, 19, p. e008856

Markers of collagen formation and degradation reflect renal function and predict adverse outcome in type 1 diabetes

Pilemann-Lyberg, S., Hansen, T. W., Tofte, N., Winther, S. A., Theilade, S., Rasmussen, D. G. K., Nielsen, S., Karsdal, M. A., Genovese, F. & Rossing, P., 2 Oct 2018, In : Diabetologia. 61, S1, p. S491 1 p., 999.

Acute hyperoxia deteriorates nerve conduction velocity in type 1 diabetes: A possible effect on oxidative stress?

Laursen, J. C., Hansen, C. S., Bordino, M., Zobel, E. H., Winther, S. A., Groop, P. -H., Frimodt-Moller, M., Bernardi, L. & Rossing, P., 1 Oct 2018, In : Diabetologia. 61, 1, p. S467 1 p., 948.

Hjertesvigt er en hyppig komplikation i forbindelse med diabetes mellitus

Hangaard, M. H., Rossing, P., Jensen, J. S. & Jensen, M. T., 1 Oct 2018, In : Ugeskrift for Laeger. 180, 20A, V02170164 .

Soluble urokinase plasminogen activator receptor predicts cardiovascular events, mortality and kidney function decline in patients with type 1 diabetes

Curovic, V. R., Theilade, S., Winther, S. A., Tofte, N., Eugen-Olsen, J., Persson, F., Hansen, T. W., Jeppesen, J. & Rossing, P., 1 Oct 2018, In : Diabetologia. 61, 1, p. S577-S578 1 p., 1183.

Cardiac repolarization and depolarization in people with Type 1 diabetes with normal ejection fraction and without known heart disease: a case-control study

Isaksen, J. L., Graff, C., Ellervik, C., Jensen, J. S., Rossing, P., Kanters, J. K. & Jensen, M. T., Oct 2018, In : Diabetic Medicine Online. 35, 10, p. 1337-1344 7 p.

Collagen Type III Degradation Is Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes with Microalbuminuria

Genovesa, F., Hansen, T. W., Rasmussen, D. G. K., Nielsen, S. H., Reinhard, H., Von Scholten, B. J., Persson, F., Jacobsen, P. K., Parving, H-H. D., Karsdal, M. A. & Rossing, P., Oct 2018, In : Diabetologia. 61, p. S492-S492 1 p., 1001.

Efficacy of long-term remote ischaemic conditioning on vascular and neuronal function in type 2 diabetes patients with peripheral arterial disease

Hansen, C. S., Jørgensen, M. E., Fleischer, J., Bøtker, H. E. & Rossing, P., Oct 2018, In : Diabetologia. 61, Suppl 1, p. S480-S480 1 p., 973.

Myocardial flow reserve assessed by Cardiac 82Rb PET/CT is associated with albumin excretion in patients with type 1 diabetes

Hansen, T. W., Zobel, E. H., Hasbak, P., Winther, S. A., Kjær, A., Holmvang, L. & Rossing, P., 20 Sep 2018, In : Journal of Hypertension. 36, e suppl 3, p. S531-S531 1 p., A3993.

Reduced risk of heart failure with intensified multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: 21 years of follow-up in the randomised Steno-2 study

Oellgaard, J., Gæde, P., Rossing, P., Rørth, R., Køber, L., Parving, H-H. & Pedersen, O., Aug 2018, In : Diabetologia. 61, 8, p. 1724-1733 9 p.

How Does Risk Screening for Kidney Disease Influence Diabetes Distress?

Joensen, L. E., Madsen, K. P., Frimodt-Møller, M., Tofte, N., Willaing, I., Lindhardt, M. K. & Rossing, P., 1 Jul 2018, In : Diabetes. 67, Supplement 1, 1 p.

A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes

van Zuydam, N. R., Ahlqvist, E., Sandholm, N., Deshmukh, H., Rayner, N. W., Abdalla, M., Ladenvall, C., Ziemek, D., Fauman, E., Robertson, N. R., McKeigue, P. M., Valo, E., Forsblom, C., Harjutsalo, V., Perna, A., Rurali, E., Marcovecchio, M. L., Igo, R. P., Salem, R. M., Perico, N., Lajer, M., Käräjämäki, A., Imamura, M., Kubo, M., Takahashi, A., Sim, X., Liu, J., van Dam, R. M., Jiang, G., Tam, C. H. T., Luk, A. O. Y., Lee, H. M., Lim, C. K. P., Szeto, C. C., So, W. Y., Chan, J. C. N., Ang, S. F., Dorajoo, R., Wang, L., Hua Clara, T. S., McKnight, A-J., Duffy, S., Pezzolesi, M. G., Marre, M., Gyorgy, B., Hadjadj, S., Ahluwalia, T. S., Linneberg, A., Rossing, P. & FINNDIANE Study centres, Jul 2018, In : Diabetes. 67, 7, p. 1414-1427 13 p.

Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria

Rasmussen, D. G. K., Hansen, T. W., von Scholten, B. J., Nielsen, S. H., Reinhard, H., Parving, H-H., Tepel, M., Karsdal, M. A., Jacobsen, P. K., Genovese, F. & Rossing, P., Jul 2018, In : Diabetes Care. 41, 7, p. 1493-1500 7 p.

Stratification of type 2 diabetes based on routine clinical markers

Safai, N., Ali, A., Rossing, P. & Ridderstråle, M., Jul 2018, In : Diabetes Research and Clinical Practice. 141, p. 275-283 8 p.

Data Pipeline for Clinical Diabetes Metabolomics - From Targeted Mass-Spectra to Patient Stratification

Suvitaival, T., Ahonen, L., Ali, A., Legido-Quigley, C., Dragsted, L. O. & Rossing, P., 28 Jun 2018.

Development and comparison of sample preparation methods for LC-MS based lipidomics on fecal samples

Ahonen, L. L., Stanstrup, J., Mattila, I., Christiansen, N., Rossing, P. & Dragsted, L. O., 4 Jun 2018.

Altered somatosensory neurovascular response in patients with Becker muscular dystrophy

Lindberg, U., Kruuse, C., Witting, N., Lundgaard, S. J., Vissing, J., Rostrup, E., Larsson, H. B. W. & Rossing, P., Jun 2018, In : Brain and Behavior. 8, 6, p. e00985 9 p.

Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in Type 2 diabetes

Tofte, N., Lindhardt, M., Adamova, K., Beige, J., Beulens, J. W. J., Birkenfeld, A. L., Currie, G., Delles, C., Dimos, I., Francová, L., Frimodt-Møller, M., Girman, P., Göke, R., Havrdova, T., Kooy, A., Mischak, H., Navis, G., Nijpels, G., Noutsou, M., Ortiz, A., Parvanova, A., Persson, F., Ruggenenti, P. L., Rutters, F., Rychlík, I., Spasovski, G., Speeckaert, M., Trillini, M., von der Leyen, H. & Rossing, P., 21 May 2018, In : Diabetic Medicine. 35, 10, p. 1375-1382 8 p.

Higher Collagen VI Formation Is Associated With All-Cause Mortality in Patients With Type 2 Diabetes and Microalbuminuria.

Hansen, T. W., Rasmussen, D., Von Scholten, B. J., Nielsen, S., Reinhard, H., Parving, H-H. D., Tepel, M., Karsdal, M., Genovese, F. & Rossing, P., 17 May 2018.

COLLAGEN TYPE III DEGRADATION IS ASSOCIATED WITH DETERIORATION OF KIDNEY FUNCTION IN PATIENTS WITH TYPE 2 DIABETES WITH MICROALBUMINURIA.

Frimodt-Moller, M., Genovese, F., Hansen, T., Rasmussen, D., Nielsen, S., Reinhard, H., von Scholten, B. J., Persson, F., Jacobsen, P., Parving, H-H., Karsdal, M. & Rossing, P., 1 May 2018, In : Nephrology Dialysis Transplantation. 33, 1, 1 p., SP418.

Decreases in weight with bardoxolone methyl in obese patients with chronic kidney disease stage 4 and type 2 diabetes - post-hoc analyses from beacon

Rossing, P., Appel, G., Block, G., Chertow, G., Chin, M., Coyne, D., Goldsberry, A., Meyer, C., Molitch, M., Pergola, P., Spinowitz, B., Sprague, S. & Raskin, P., 1 May 2018, In : Nephrology Dialysis Transplantation. 33, 1, 1 p., SP104.

Effect of bardoxolone methyl treatment on urinary albumin in patients with type 2 diabetes and chronic kidney disease - post-hoc analysis from beam and beacon

Rossing, P., Block, G., Chertow, G., Chin, M., Goldsberry, A., McCullough, P., Meyer, C., Packham, D., Spinowitz, B., Sprague, S., Warnock, D. & Pergola, P., 1 May 2018, In : Nephrology Dialysis Transplantation. 33, 1, FP152.

Effect of dapagliflozin on albuminuria and the renin-angiotensin system when added to renin-angiotensin blockade in patients with type 2 diabetes and nephropathy

Eickhoff, M., Frimodt-Moller, M., Jorgensen, N. R., Rossing, P. & Persson, F., 1 May 2018, In : Nephrology Dialysis Transplantation. 33, 1, SP417 .

Prevalence of heart failure with preserved and reduced left ventricular ejection fraction and diagnostic value of MR-proANP in 803 outpatients with type 2 diabetes

Jensen, J., Schou, M., Kistorp, C., Faber, J., Hansen, T. W., Jensen, M. T., Andersen, H. U., Rossing, P., Vilsboll, T., Jensen, J. S. & Jorgensen, P. G., 1 May 2018, In : European Journal of Heart Failure. 20, S1, p. 432 1 p.

Serum uric acid and progression of diabetic nephropathy in type 1 diabetes

Pilemann-Lyberg, S., Lindhardt, M., Persson, F., Andersen, S. & Rossing, P., 1 May 2018, In : Journal of Diabetes and its Complications. 32, 5, p. 470-473 3 p.

Aldosterone Blockade Added to Renin-Angiotensin System Blockade to Reduce Albuminuria-A Path for Improved Renoprotection?

Rossing, P. & Persson, F., May 2018, In : Medecine/Sciences. 355, 5, p. 407-408 2 p.

Altered levels of plasma lipids are associated with diabetic kidney disease: a cross-sectional study of plasma lipidomics in type 1 diabetes

Tofte, N., Suvitaival, T., Ahonen, L. L., Theilade, S., Ahluwalia, T. S., Frimodt-Møller, M. & Rossing, P., May 2018, In : Nephrology Dialysis Transplantation. 33, Suppl 1, 1 p., SP420 .

Subclassification of diabetes based on quantitative traits

Rossing, P., May 2018, In : Nature Reviews Nephrology. 14, p. 355-356 1 p.

Novel risk genes identified in a genome-wide association study for coronary artery disease in patients with type 1 diabetes

Charmet, R., Duffy, S., Keshavarzi, S., Gyorgy, B., Marre, M., Rossing, P., McKnight, A. J., Maxwell, A. P., Ahluwalia, T. V. S., Paterson, A. D., Trégouët, D-A. & Hadjadj, S., 25 Apr 2018, In : Cardiovascular Diabetology. 17, 1, p. 61

Uric acid is not associated with diabetic nephropathy and other complications in type 1 diabetes

Pilemann-Lyberg, S., Hansen, T. W., Persson, F., Theilade, S., Singh Ahluwalia, T., Frystyk, J. & Rossing, P., 11 Apr 2018, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 8 p.

Prognosis and treatment of diabetic nephropathy: Recent advances and perspectives

Rossing, P., Persson, F. & Frimodt-Møller, M., Apr 2018, In : Nephrologie & Therapeutique. 14 Suppl 1, p. S31-S37

Associations between advanced glycation endproducts and matrix metalloproteinases and its inhibitor in individuals with type 1 diabetes

Peeters, S. A., Engelen, L., Buijs, J., Theilade, S., Rossing, P., Schalkwijk, C. G. & Stehouwer, C. D. A., 1 Mar 2018, In : Journal of Diabetes and its Complications. 32, 3, p. 325-329 4 p.

The effect of uric acid lowering treatment on albuminuria and renal function in Type 1 diabetes: a randomized clinical trial

Pilemann-Lyberg, S., Persson, F., Frystyk, J. & Rossing, P., Mar 2018, In : Diabetic Medicine Online. 35, 3, p. 392-393 1 p.

Predicting albuminuria response to spironolactone treatment with urinary proteomics in patients with type 2 diabetes and hypertension

Lindhardt, M., Persson, F., Oxlund, C. S., Jacobsen, I. A., Zürbig, P., Mischak, H., Rossing, P. & Heerspink, H. J. L., Feb 2018, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 33, 2, p. 296–303 7 p.

Diagnosis of diabetic kidney disease: state of the art and future perspective

Persson, F. & Rossing, P., 1 Jan 2018, In : Kidney International Supplements. 8, 1, p. 2-7 6 p.

Arterial-ventricular coupling in type 1 diabetes: arterial stiffness is associated with impaired global longitudinal strain in type 1 diabetes patients-the Thousand & 1 Study

Theilade, S., Rossing, P., Jensen, J. S. & Jensen, M. T., Jan 2018, In : Acta Diabetologica. 55, 1, p. 21-29 8 p.

Biomarkers of inflammation and endothelial dysfunction as predictors of pulse pressure and incident hypertension in type 1 diabetes: a 20 year life-course study in an inception cohort

Ferreira, I., Hovind, P., Schalkwijk, C. G., Parving, H-H., Stehouwer, C. D. A. & Rossing, P., Jan 2018, In : Diabetologia. 61, 1, p. 231-241 10 p.

A Prospective Cohort Study in Patients with Type 2 Diabetes Mellitus for Validation of Biomarkers (PROVALID) - Study Design and Baseline Characteristics

Eder, S., Leierer, J., Kerschbaum, J., Rosivall, L., Wiecek, A., de Zeeuw, D., Mark, P. B., Heinze, G., Rossing, P., Heerspink, H. L. & Mayer, G., 2018, In : Kidney & blood pressure research. 43, 1, p. 181-190 10 p.

Clinical Features and Natural Course of Diabetic Nephropathy

Rossing, P. & Frimodt-Møller, M., 2018, Diabetic Nephropathy: Pathophysiology and Clinical Aspects. Roelof, J. & Vogt, L. (eds.). 1 ed. Springer International Publishing, p. 21-33

Effects of Dapagliflozin on Albuminuria, Renal Function, and Renin-Angiotensin-Aldosterone Hormones in Type 2 Diabetes

Eickhoff, M. K., Frimodt-Møller, M., Jørgensen, N. R., Rossing, P. & Persson, F., 2018, In : Journal of the American Society of Nephrology. p. 770 1 p., SA-PO138.

Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up study

Frimodt-Møller, M., von Scholten, B. J., Reinhard, H., Jacobsen, P. K., Hansen, T. W., Persson, F. I., Parving, H-H. & Rossing, P., 2018, In : P L o S One. 13, 4, p. e0196634

Plasma lipids are associated with diabetic kidney disease: a study of plasma lipidomics in type 1 diabetes

Tofte, N., Suvitaival, T., Ahonen, L. L., Theilade, S., Winther, S. A., Frimodt-Møller, M., Ahluwalia, T. S. & Rossing, P., 2018, In : Diabetologia. 61, suppl 1, p. S497-S497 1 p., 1011.

Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysis

Siwy, J., Zürbig, P., Argilés, A., Beige, J., Haubitz, M., Jankowski, J., Julian, B. A., Linde, P. G., Marx, D., Mischak, H., Mullen, W., Novak, J., Ortiz, A., Persson, F., Pontillo, C., Rossing, P., Rupprecht, H., Schanstra, J. P., Vlahou, A. & Vanholder, R., Dec 2017, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention

Petrykiv, S. I., Laverman, G. D., Persson, F., Vogt, L., Rossing, P., de Borst, M. H., Gansevoort, R. T., de Zeeuw, D. & Heerspink, H. J. L., 7 Nov 2017, In : Clinical journal of the American Society of Nephrology : CJASN. 12, 11, p. 1804-1813 9 p.

Fasting Plasma Trimethylamine-N-Oxide as a Risk Marker of Poor Renal Outcomes, Cardiovascular Disease, and Mortality in Patients with Type 1 Diabetes with Diabetic Nephropathy

Winther, S. A., Øllgaard, J. C., Parving, H-H. D., Hazen, S. L., Pedersen, O. & Rossing, P., 4 Nov 2017, In : Journal of the American Society of Nephrology. 28, p. 102-103 SA-OR113.

Symmetric and Asymmetric Dimethylarginine as Risk Markers of Cardiovascular Disease, All-Cause Mortality, and Deterioration in Kidney Function in Patients with Type 2 Diabetes and Microalbuminuria

Persson, F., Zobel, E. H., von Scholten, B. J., Hansen, T. W., Parving, H-H. D. & Rossing, P., 4 Nov 2017. 1 p.

A Novel Marker of Collagen Type VI Formation Is Prognostic for Cardiovascular Disease, All-Cause Mortality, and Deterioration of Kidney Function in Patients with Type 2 Diabetes with Microalbuminuria

Guldager, D. K. R., Hansen, T. W., Nielsen, S. H., Reinhard, H., Parving, H-H. D., Karsdal, M. A., Genovese, F. & Rossing, P., 3 Nov 2017. 1 p.

Collagen Type III Degradation Is Associated with Deterioration of Kidney Function in Patients with Type 2 Diabetes with Microalbuminuria

Genovese, F., Hansen, T. W., Guldager, D. K. R., Nielsen, S. H., Reinhard, H., Parving, H-H. D., Karsdal, M. A. & Rossing, P., 3 Nov 2017. 1 p.

GDF-15 and FGF-23 Are Associated with Mortality in Type 2 Diabetic Patients with Microalbuminuria

Frimodt-Møller, M., von Scholten, B. J., Reinhard, H., Hansen, T. W., Persson, F., Parving, H-H. D. & Rossing, P., 3 Nov 2017. 1 p.

Is Urinary KIM-1 a Predictor of EGFR Decline, Incident Cardiovascular Disease, and All Cause Mortality?

Eickhoff, M. K., von Scholten, B. J., Reinhard, H., Hansen, T. W., Persson, F., Parving, H-H. D. & Rossing, P., 3 Nov 2017. 1 p.

Reduced Sublingual Endothelial Glycocalyx in Type 1 Diabetic Patients with Diabetic Nephropathy

Winther, S. A., Frimodt-Møller, M., Zobel, E. H., Hansen, T. W. & Rossing, P., 3 Nov 2017, In : Journal of the American Society of Nephrology. 28, p. 575 1 p., FR-PO666.

Serum and Urine Markers of Collagen Type VI Formation (Pro-C6) and Type III Degradation (C3M) Reflect Renal Function in Type 1 Diabetes

Hansen, T. W., Guldager, D. K. R., Pilemann-Lyberg, S., Nielsen, S. H., Karsdal, M. A., Persson, F., Theilade, S., Genovese, F. & Rossing, P., 3 Nov 2017. 1 p.

The Effect of Uric Acid Lowering on Albuminuria and Renal Function in Type 1 Diabetes: A Randomized Clinical Trial

Pilemann-Lyberg, S., Persson, F., Frystyk, J. & Rossing, P., 2 Nov 2017. 1 p.

Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy

Galsgaard, J., Persson, F., Hansen, T. W., Jorsal, A., Tarnow, L., Parving, H-H. & Rossing, P., Nov 2017, In : Kidney International. 92, 5, p. 1242-1248 6 p.

Prediction of Chronic Kidney Disease Stage 3 by CKD273, a Urinary Proteomic Biomarker

Pontillo, C., Zhang, Z-Y., Schanstra, J. P., Jacobs, L., Zürbig, P., Thijs, L., Ramírez-Torres, A., Heerspink, H. J. L., Lindhardt, M., Klein, R., Orchard, T., Porta, M., Bilous, R. W., Charturvedi, N., Rossing, P., Vlahou, A., Schepers, E., Glorieux, G., Mullen, W., Delles, C., Verhamme, P., Vanholder, R., Staessen, J. A., Mischak, H. & Jankowski, J., Nov 2017, In : Kidney International Reports. 2, 6, p. 1066-1075 10 p.

Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study

Lindhardt, M., Persson, F. I., Zürbig, P., Stalmach, A., Mischak, H., de Zeeuw, D., Lambers Heerspink, H., Klein, R., Orchard, T., Porta, M., Fuller, J., Bilous, R., Chaturvedi, N., Parving, H-H. & Rossing, P., Nov 2017, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 32, 11, p. 1866-1873 7 p.

Presence of micro- and macroalbuminuria and the association with cardiac mechanics in patients with type 2 diabetes

Jørgensen, P. G., Biering-Sørensen, T., Mogelvang, R., Fritz-Hansen, T., Vilsbøll, T., Rossing, P. & Jensen, J. S., 3 Oct 2017, In : European heart journal cardiovascular Imaging. p. 0-8 8 p.

Toe-brachial index as a predictor of cardiovascular disease and all-cause mortality in people with type 2 diabetes and microalbuminuria

Zobel, E. H., von Scholten, B. J., Reinhard, H., Persson, F., Hansen, T. W., Parving, H. H., Jacobsen, P. K. & Rossing, P., Oct 2017, In : Diabetologia. 60, 10, p. 1883-1891 8 p.

Cluster analyses of patients with dysregulated type 2 diabetes based on routine clinical markers reveal cluster-specific prevalence of diabetes complications

Ali, A., Safai, N., Rossing, P. & Ridderstråle, M., 13 Sep 2017.

Reduced sublingual endothelial glycocalyx in type 1 diabetic patients with diabetic nephropathy

Winther, S. A., Frimodt-Møller, M., Zobel, E. H., Hansen, T. W. & Rossing, P., 13 Sep 2017, In : Diabetologia. 60, p. S499 1 p., 1084.

Risk of heart failure in intensively treated patients with type 2 diabetes and microalbuminuria: 21 years follow-up in the multifactorial Steno-2 intervention

Øllgaard, J. C., Gæde, P., Rørth, R., Rossing, P., Køber, L., Parving, H-H. D. & Pedersen, O., 13 Sep 2017. 1 p.

GDF-15 and FGF-23 are associated with mortality in type 2 diabetic patients with microalbuminuria

Frimodt-Møller, M., von Scholten, B. J., Reinhard, H., Hansen, T. W., Persson, F., Parving, H-H. D. & Rossing, P., 12 Sep 2017. 1 p.

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, mortality and deterioration in kidney function in patients with type 2 diabetes

Hansen, T. W., Zobel, E. H., von Scholten, B. J., Reinhard, H., Persson, F., Teerlink, T., Parving, H-H. D., Jacobsen, P. K. & Rossing, P., 12 Sep 2017. 1 p.

Higher plasma methylglyoxal levels are associated with incident cardiovascular disease in individuals with type 1 diabetes: a 12-year follow-up study

Hanssen, N. M. J., Scheijen, J. L. J., Jorsal, A., Parving, H-H., Tarnow, L., Rossing, P., Stehouwer, C. D. A. & Schalkwijk, C. G., 1 Sep 2017, p. S511. 1 p.

A urinary proteome-based classifier for the early detection of decline in glomerular filtration

Pontillo, C., Jacobs, L., Staessen, J. A., Schanstra, J. P., Rossing, P., Heerspink, H. J. L., Siwy, J., Mullen, W., Vlahou, A., Mischak, H., Vanholder, R., Zürbig, P. & Jankowski, J., Sep 2017, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 32, 9, p. 1510-1516 6 p.

Diabetes and Hypertension: A Position Statement by the American Diabetes Association

de Boer, I. H., Bangalore, S., Benetos, A., Davis, A. M., Michos, E. D., Muntner, P., Rossing, P., Zoungas, S. & Bakris, G. L., Sep 2017, In : Diabetes Care. 40, 9, p. 1273-1284 12 p.

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

Petrie, J. R., Chaturvedi, N., Ford, I., Brouwers, M. C. G. J., Greenlaw, N., Tillin, T., Hramiak, I., Hughes, A. D., Jenkins, A. J., Klein, B. E. K., Klein, R., Ooi, T. C., Rossing, P., Stehouwer, C. D. A., Sattar, N., Colhoun, H. M. & REMOVAL Study Group, Aug 2017, In : The Lancet Diabetes and Endocrinology. 5, 8, p. 597-609 12 p.

Challenges in conducting clinical trials in nephrology: conclusions from a Kidney Disease-Improving Global Outcomes (KDIGO) Controversies Conference

Baigent, C., Herrington, W. G., Coresh, J., Landray, M. J., Levin, A., Perkovic, V., Pfeffer, M. A., Rossing, P., Walsh, M., Wanner, C., Wheeler, D. C., Winkelmayer, W. C. & McMurray, J. J. V., Aug 2017, In : Kidney International. 92, 2, p. 297-305 9 p.

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria

Zobel, E. H., von Scholten, B. J., Reinhard, H., Persson, F., Teerlink, T., Hansen, T. W., Parving, H-H., Jacobsen, P. K. & Rossing, P., 11 Jul 2017, In : Cardiovascular Diabetology. 16, 1, p. e88

Effect of weight reductions on estimated kidney function: Post-hoc analysis of two randomized trials

von Scholten, B. J., Davies, M. J., Persson, F., Hansen, T. W., Madsbad, S., Endahl, L., Jepsen, C. H. & Rossing, P., Jul 2017, In : Journal of Diabetes and its Complications. 31, 7, p. 1164-1168 5 p.

Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes

Krolewski, A. S., Skupien, J., Rossing, P. & Warram, J. H., 1 Jun 2017, In : Kidney International. 91, 6, p. 1300-1311 12 p.

Liraglutide effects on cardiovascular risk biomarkers in patients with type 2 diabetes and albuminuria: A sub-analysis of a randomised, placebo-controlled, double-blind, cross-over trial

von Scholten, B. J., Persson, F., Rosenlund, S., Eugen-Olsen, J., Pielak, T., Faber, J., Hansen, T. W. & Rossing, P., 1 Jun 2017, In : Diabetes, Obesity and Metabolism. 19, 6, p. 901-905

Variability in response to albuminuria-lowering drugs: true or random?

Petrykiv, S. I., de Zeeuw, D., Persson, F., Rossing, P., Gansevoort, R. T., Laverman, G. D. & Heerspink, H. J. L., 1 Jun 2017, In : British Journal of Clinical Pharmacology. 83, 6, p. 1197-1204 8 p.

Comparison of manual and automated sample preparation techniques for lipidomics

Ahonen, L. & Rossing, P., Jun 2017.

Incident microalbuminuria and complement factor mannan-binding lectin-associated protein 19 in people with newly diagnosed type 1 diabetes

Ostergaard, J. A., Thiel, S., Hoffmann-Petersen, I. T., Hovind, P., Parving, H-H., Tarnow, L., Rossing, P. & Hansen, T. K., Apr 2017, In : Diabetes - Metabolism: Research and Reviews (Online). 33, 5, p. e2895

Intensified multifactorial intervention in type 2 diabetics with microalbuminuria leads to long-term renal benefits

Oellgaard, J., Gaede, P., Rossing, P., Persson, F., Parving, H-H. & Pedersen, O., Apr 2017, In : Kidney International. 91, 4, p. 982-988 7 p.

Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial

Petrie, J. R., Chaturvedi, N., Ford, I., Hramiak, I., Hughes, A. D., Jenkins, A. J., E Klein, B., Klein, R., Ooi, T. C., Rossing, P., Sattar, N., Stehouwer, C. D. A., Colhoun, H. M. & REMOVAL Trial Team, Apr 2017, In : Diabetes, Obesity and Metabolism. 19, 4, p. 509-516 8 p.

Effect of Pancreatic Hormones on pro-Atrial Natriuretic Peptide in Humans

Zois, N. E., Terzic, D., Færch, K., Plomgaard, P., Hansen, J. S., Rossing, P. & Goetze, J. P., Mar 2017, In : EBioMedicine. 17, p. 88-94 7 p.

Systems Biology-Derived Biomarkers to Predict Progression of Renal Function Decline in Type 2 Diabetes

Mayer, G., Heerspink, H. J. L., Aschauer, C., Heinzel, A., Heinze, G., Kainz, A., Sunzenauer, J., Perco, P., de Zeeuw, D., Rossing, P., Pena, M. J., Oberbauer, R. & SYSKID Consortium, Mar 2017, In : Diabetes Care. 40, 3, p. 391-397 7 p.

Effect of large weight reductions on measured and estimated kidney function

von Scholten, B. J., Persson, F., Svane, M. S., Hansen, T. W., Madsbad, S. & Rossing, P., 1 Feb 2017, In : BMC Nephrology. 18, 1, p. 52

The effect of liraglutide on renal function: A randomized clinical trial

von Scholten, B. J., Persson, F., Rosenlund, S., Hovind, P., Faber, J., Hansen, T. W. & Rossing, P., Feb 2017, In : Diabetes, Obesity and Metabolism. 19, 2, p. 239-247

The Genetic Landscape of Renal Complications in Type 1 Diabetes

Sandholm, N., van Zuydam, N. R., Ahlqvist, E., Juliusdottir, T., Deshmukh, H. A., Rayner, N. W., Di Camillo, B., Forsblom, C., Fadista, J., Ziemek, D., Salem, R. M., Hiraki, L. T., Pezzolesi, M. G., Tregouet, D., Dahlström, E., Valo, E., Oskolkov, N., Ladenvall, C., Marcovecchio, M. L., Cooper, J. D., Sambo, F., Malovini, A., Manfrini, M., McKnight, A. J., Lajer, M. S., Harjutsalo, V., Gordin, D., Parkkonen, M., Lyssenko, V., McKeigue, P. M., Rich, S. S., Brosnan, M. J., Fauman, E., Bellazzi, R., Rossing, P., Hadjadj, S., Krolewski, A. S., Paterson, A. D., Hirschhorn, J. N., Maxwell, A. P., Cobelli, C., Colhoun, H. M., Groop, L., McCarthy, M. I., Groop, P-H. & FinnDiane Study Group, Jaakko Tuomilehto, Feb 2017, In : Journal of the American Society of Nephrology : JASN. 28, 2, p. 557-574 18 p.

Pleiotropic effects of liraglutide treatment on renal risk factors in type 2 diabetes: Individual effects of treatment

Zobel, E. H., von Scholten, B. J., Lindhardt, M., Persson, F., Hansen, T. W. & Rossing, P., Jan 2017, In : Journal of Diabetes and its Complications. 31, 1, p. 162-168 7 p.

Circulating matrix metalloproteinases are associated with arterial stiffness in patients with type 1 diabetes: pooled analysis of three cohort studies

Peeters, S. A., Engelen, L., Buijs, J., Chaturvedi, N., Fuller, J. H., Jorsal, A., Parving, H-H., Tarnow, L., Theilade, S., Rossing, P., Schalkwijk, C. G. & Stehouwer, C. D. A., 2017, In : Cardiovascular Diabetology. 16, 1, p. e139

Epicardial, pericardial and total cardiac fat and cardiovascular disease in type 2 diabetic patients with elevated urinary albumin excretion rate

Christensen, R. H., von Scholten, B. J., Hansen, C. S., Heywood, S. E., Rosenmeier, J. B., Andersen, U. B., Hovind, P., Reinhard, H., Parving, H-H., Pedersen, B. K., Jørgensen, M. E., Jacobsen, P. K. & Rossing, P., 2017, In : European journal of preventive cardiology. 24, 14, p. 1517-1524

Higher Parathyroid Hormone Level Is Associated With Increased Arterial Stiffness in Type 1 Diabetes

Zobel, E. H., Theilade, S., Johan von Scholten, B., Persson, F., Tarnow, L., Lajer, M., Hansen, T. W. & Rossing, P., 2017, In : Diabetes Care. 40, 3, p. e32-e33

Higher Plasma Methylglyoxal Levels are Associated with Incident Cardiovascular Disease in Individuals with Type 1 Diabetes: a 12-Year Follow-Up Study

Hanssen, N. M. J., Scheijen, J. L. J. M., Jorsal, A., Parving, H-H., Tarnow, L., Rossing, P., Stehouwer, C. D. A. & Schalkwijk, C. G., 2017, In : Diabetes. 66, 8, p. 2278-83

Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study

Peeters, S. A., Engelen, L., Buijs, J., Jorsal, A., Parving, H-H., Tarnow, L., Rossing, P., Schalkwijk, C. G. & Stehouwer, C. D. A., 2017, In : Cardiovascular Diabetology. 16, 1, p. e55

Reduced sublingual endothelial glycocalyx in type 1 diabetic patients with diabetic nephropathy

Winther, S. A., Frimodt-Møller, M., Zobel, E. H., Hansen, T. W. & Rossing, P., 2017.

Reduced sublingual endothelial glycocalyx in type 1 diabetics with diabetic nephropathy

Winther, S. A., Frimodt-Møller, M., Zobel, E. H., Hansen, T. W. & Rossing, P., 2017.

Three-phase bone scintigraphy for diagnosis of Charcot neuropathic osteoarthropathy in the diabetic foot - does quantitative data improve diagnostic value?

Fosbøl, M., Reving, S., Petersen, E. H., Rossing, P., Lajer, M. & Zerahn, B., 2017, In : Clinical Physiology and Functional Imaging. 37, 1, p. 30-36

Trimethylamine N-oxide (TMAO) as a new potential therapeutic target for insulin resistance and cancer

Oellgaard, J., Winther, S. A., Hansen, T. S., Rossing, P. & von Scholten, B. J., 2017, In : Current Pharmaceutical Design. 23, 25, p. 3699-3712 14 p.

Global Changes in Food Supply and the Obesity Epidemic

Zobel, E. H., Hansen, T. W., Rossing, P. & von Scholten, B. J., Dec 2016, In : Current Obesity Reports. 5, 4, p. 449-455 7 p.

Methylglyoxal is associated with changes in kidney function among individuals with screen-detected Type 2 diabetes mellitus

Jensen, T. M., Vistisen, D., Fleming, T., Nawroth, P., Rossing, P., Jørgensen, M. E., Lauritzen, T., Sandbæk, A. & Witte, D. R., 15 Nov 2016, In : Diabetic Medicine Online. 33, 12, p. 1625-1631 7 p.

Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial

Gæde, P., Øllgaard, J. C., Carstensen, B., Rossing, P., Lund-Andersen, H., Parving, H-H. & Pedersen, O., Nov 2016, In : Diabetologia. 59, 11, p. 2298-307 10 p.

Cardiac Autonomic Function Is Associated With the Coronary Microcirculatory Function in Patients With Type 2 Diabetes

von Scholten, B. J., Hansen, C. S., Hasbak, P., Kjaer, A., Rossing, P. & Hansen, T. W., Oct 2016, In : Diabetes. 65, 10, p. 3129-38 10 p.

Cholesterol remnants and triglycerides are associated with decreased myocardial function in patients with type 2 diabetes

Jørgensen, P. G., Jensen, M. T., Biering-Sørensen, T., Mogelvang, R., Galatius, S., Fritz-Hansen, T., Rossing, P., Vilsbøll, T. & Jensen, J. S., 22 Sep 2016, In : Cardiovascular Diabetology. 15, 1, p. 137

Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics

Jørgensen, P. G., Jensen, M. T., Mogelvang, R., von Scholten, B. J., Bech, J., Fritz-Hansen, T., Galatius, S., Biering-Sørensen, T., Andersen, H. U., Vilsbøll, T., Rossing, P. & Jensen, J. S., Sep 2016, In : Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease. 13, 5, p. 321-30 10 p.

Impact of type 2 diabetes and duration of type 2 diabetes on cardiac structure and function

Jørgensen, P. G., Jensen, M. T., Mogelvang, R., Fritz-Hansen, T., Galatius, S., Biering-Sørensen, T., Storgaard, H., Vilsbøll, T., Rossing, P. & Jensen, J. S., 5 Jul 2016, In : International Journal of Cardiology. 221, p. 114-121 8 p.

Serum metabolites predict response to angiotensin II receptor blockers in patients with diabetes mellitus

Pena, M. J., Heinzel, A., Rossing, P., Parving, H-H., Dallmann, G., Rossing, K., Andersen, S., Mayer, B. & Heerspink, H. J. L., 5 Jul 2016, In : Journal of Translational Medicine. 14, 1, p. 203

Prevention of microalbuminuria using early intervention with renin-angiotensin system inhibitors in patients with type 2 diabetes: A systematic review

Persson, F. I., Lindhardt, M., Rossing, P. & Parving, H-H., Jul 2016, In : Journal of the renin-angiotensin-aldosterone system : JRAAS. 17, 3, p. pii: 1470320316652047

Self-reported dyspnea is associated with impaired global longitudinal strain in ambulatory type 1 diabetes patients with normal ejection fraction and without known heart disease - The Thousand & 1 Study

Jensen, M. T., Risum, N., Rossing, P. & Jensen, J. S., Jul 2016, In : Journal of Diabetes and its Complications. 30, 5, p. 928-34 7 p.

Urinary biomarkers are associated with incident cardiovascular disease, all-cause mortality and deterioration of kidney function in type 2 diabetic patients with microalbuminuria

von Scholten, B. J., Reinhard, H., Hansen, T. W., Oellgaard, J. C., Parving, H-H., Jacobsen, P. K. & Rossing, P., Jul 2016, In : Diabetologia. 59, 7, p. 1549-57 9 p.

Early myocardial impairment in type 1 diabetes patients without known heart disease assessed with tissue Doppler echocardiography: The Thousand & 1 study

Jensen, M. T., Sogaard, P., Andersen, H. U., Gustafsson, I., Bech, J., Hansen, T. F., Theilade, S., Almdal, T., Rossing, P. & Jensen, J. S., Jun 2016, In : Diabetes & vascular disease research : official journal of the International Society of Diabetes and Vascular Disease. 13, 4, p. 260-267

Plasma soluble urokinase plasminogen activator receptor (suPAR) level is associated with myocardial impairment assessed with advanced echocardiography in Type 1 Diabetes Patients with normal ejection fraction and without known heart disease or end stage renal disease

Theilade, S., Rossing, P., Eugen-Olsen, J., Jensen, J. S. & Jensen, M. T., Jun 2016, In : European journal of endocrinology / European Federation of Endocrine Societies. 174, 6, p. 745-753

Retinopathy is associated with impaired myocardial function assessed by advanced echocardiography in type 1 diabetes patients - The Thousand & 1 Study

Nouhravesh, N., Andersen, H. U., Jensen, J. S., Rossing, P. & Jensen, M. T., Jun 2016, In : Diabetes Research and Clinical Practice. 116, p. 263-9 7 p.

Cardiac time intervals and the association with 2D-speckle-tracking, tissue Doppler and conventional echocardiography: the Thousand&1 Study

Biering-Sørensen, T., Jensen, J. S., Andersen, H. U., Rossing, P. & Jensen, M. T., May 2016, In : The international journal of cardiovascular imaging. 32, 5, p. 789-98 10 p.

Impaired coronary microcirculation in type 2 diabetic patients is associated with elevated circulating regulatory T cells and reduced number of IL-21R⁺ T cells

von Scholten, B. J., Rosendahl, A., Hasbak, P., Bergholdt, R., Kjaer, A., Rossing, P. & Hansen, T. W., 19 Apr 2016, In : Cardiovascular Diabetology. 15, p. 67

Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy in TYpe 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial

Lindhardt, M., Persson, F., Currie, G., Pontillo, C., Beige, J., Delles, C., von der Leyen, H., Mischak, H., Navis, G., Noutsou, M., Ortiz, A., Ruggenenti, P. L., Rychlik, I., Spasovski, G. & Rossing, P., 2 Mar 2016, In : B M J Open. 6, 3, p. e010310

Cardiac (82)Rb PET/CT for fast and non-invasive assessment of microvascular function and structure in asymptomatic patients with type 2 diabetes

von Scholten, B. J., Hasbak, P., Christensen, T. E., Ghotbi, A. A., Kjaer, A., Rossing, P. & Hansen, T. W., Feb 2016, In : Diabetologia. 59, 2, p. 371-8 8 p.

Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment (LIRA-RENAL): A Randomized Clinical Trial

Davies, M. J., Bain, S. C., Atkin, S. L., Rossing, P., Scott, D. A., Shamkhalova, M. S., Bosch-Traberg, H., Syrén, A. & Umpierrez, G. E., Feb 2016, In : Diabetes Care. 39, 2, p. 222-30 9 p.

Angiogenic microRNAs Linked to Incidence and Progression of Diabetic Retinopathy in Type 1 Diabetes

Zampetaki, A., Willeit, P., Burr, S., Yin, X., Langley, S. R., Kiechl, S., Klein, R., Rossing, P., Chaturvedi, N. & Mayr, M., 1 Jan 2016, In : Diabetes. 65, 1, p. 216-27 12 p.

Several Conventional Risk Markers Suggesting Presence of Albuminuria Are Weak Among Rural Africans With Hypertension

Rasmussen, J. B., Nordin, L. S., Thomsen, J. A., Rossing, P., Bygbjerg, I. C. & Christensen, D. L., Jan 2016, In : Journal of Clinical Hypertension. 18, 1, p. 27-30 4 p.

Statins are independently associated with increased HbA1c in type 1 diabetes - The Thousand & 1 Study

Jensen, M. T., Andersen, H. U., Rossing, P. & Jensen, J. S., Jan 2016, In : Diabetes Research and Clinical Practice. 111, p. 51-7 7 p.

Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci

Nexø, B. A., Villesen, P., Nissen, K. K., Lindegaard, H. M., Rossing, P., Petersen, T., Tarnow, L., Hansen, B., Lorenzen, T., Hørslev-Petersen, K., Jensen, S. B., Bahrami, S., Lajer, M., Schmidt, K., Parving, H-H. D., Junker, P. & Laska, M. J., 2016, In : Immunologic Research. 64, 1, p. 55-63

Diabetic Nephropathy

Rossing, P., Fioretto, P., Feldt-Rasmussen, B. F. & Parving, H-H., 2016, Brenner and Rector`s The Kidney. 10 ed. Elsevier, p. 1283-1321 39 p.

Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis

Currie, G., Taylor, A. H. M., Fujita, T., Ohtsu, H., Lindhardt, M., Rossing, P., Boesby, L., Edwards, N. C., Ferro, C. J., Townend, J. N., van den Meiracker, A. H., Saklayen, M. G., Oveisi, S., Jardine, A. G., Delles, C., Preiss, D. J. & Mark, P. B., 2016, In : BMC Nephrology. 17, 1, p. 127

Glucose-Dependent Insulinotropic Polypeptide (GIP) Stimulates Osteopontin Expression in the Vasculature via Endothelin-1 and CREB

Berglund, L. M., Lyssenko, V., Ladenvall, C., Kotova, O., Edsfeldt, A., Pilgaard, K., Alkayyali, S., Brøns, C., Forsblom, C., Jonsson, A., Zetterqvist, A. V., Nitulescu, M., McDavitt, C. R., Dunér, P., Stancáková, A., Kuusisto, J., Ahlqvist, E., Lajer, M., Tarnow, L., Madsbad, S., Rossing, P., Kieffer, T. J., Melander, O., Orho-Melander, M., Nilsson, P., Groop, P-H., Vaag, A., Lindblad, B., Gottsäter, A., Laakso, M., Goncalves, I., Groop, L. & Gomez, M. F., 2016, In : Diabetes. 65, 1, p. 239-254

High osteoprotegerin is associated with development of foot ulcer in type 1 diabetes

Zobel, E. H., von Scholten, B. J., Lajer, M., Jorsal, A., Tarnow, L., Rasmussen, L. M., Holstein, P., Parving, H-H., Hansen, T. W. & Rossing, P., 2016, In : Journal of Diabetes and its Complications. 30, 8, p. 1603-08

Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuria

von Scholten, B. J., Reinhard, H., Hansen, T. W., Schalkwijk, C. G., Stehouwer, C., Parving, H-H., Jacobsen, P. K. & Rossing, P., 2016, In : Journal of Diabetes and its Complications. 30, 2, p. 248-55

Renin angiotensin system blockade reduces urinary levels of soluble urokinase plasminogen activator receptor (suPAR) in patients with type 2 diabetes

Persson, F., Theilade, S., Eugen-Olsen, J., Rossing, P. & Parving, H-H., 2016, In : Journal of Diabetes and its Complications. 30, 8, p. 1440-42

The Danish Adult Diabetes Registry

Jørgensen, M. E., Kristensen, J. K., Reventlov Husted, G., Cerqueira, C. & Rossing, P., 2016, In : Clinical Epidemiology. 8, p. 429-434 6 p.

Cuff inflations do not affect night-time blood pressure: comparison of 24 h ambulatory blood pressure measured by a cuff and a tonometric device in type 2 diabetes

Zobel, E. H., Theilade, S., Hansen, T. W., Lindhardt, M. K. & Rossing, P., Dec 2015, In : Blood Pressure Monitoring. 20, 6, p. 369-72 4 p.

Increased All-Cause Mortality in Patients With Type 1 Diabetes and High-Expression Mannan-Binding Lectin Genotypes: A 12-Year Follow-up Study

Østergaard, J. A., Thiel, S., Lajer, M., Steffensen, R., Parving, H-H., Flyvbjerg, A., Rossing, P., Tarnow, L. & Hansen, T. K., Oct 2015, In : Diabetes Care. 38, 10, p. 1898-903 6 p.

Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetes

Pena, M. J., Jankowski, J., Heinze, G., Kohl, M., Heinzel, A., Bakker, S. J. L., Gansevoort, R. T., Rossing, P., de Zeeuw, D., Heerspink, H. J. L. & Jankowski, V., Oct 2015, In : Journal of Hypertension. 33, 10, p. 2123-32 10 p.

Effect of sensor-augmented pump treatment vs. multiple daily injections on albuminuria: a 1 year randomized study

Vestergaard Rosenlund, S., Willum Hansen, T., Rossing, P. & Andersen, S., 21 Sep 2015, In : The Journal of clinical endocrinology and metabolism. 100, 11, p. 4181-88 jc20152839.

The influence of pharmaceutically induced weight changes on estimates of renal function: A patient-level pooled analysis of seven randomised controlled trials of glucose lowering medication

von Scholten, B. J., Ørsted, D. D., Svendsen, A. L., Persson, F. & Rossing, P., 9 Sep 2015, In : Journal of Diabetes and its Complications. 29, 8, p. 1146-51 6 p.

Effect of 4 years subcutaneous insulin infusion treatment on albuminuria, kidney function and HbA1c compared with multiple daily injections: a longitudinal follow-up study

Vestergaard Rosenlund, S., Hansen, T. W., Andersen, S. & Rossing, P., 2 Sep 2015, In : Diabetic Medicine Online. 32, 11, p. 1445-52

Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial

Bakris, G. L., Agarwal, R., Chan, J. C., Cooper, M. E., Gansevoort, R. T., Haller, H., Remuzzi, G., Rossing, P., Schmieder, R. E., Nowack, C., Kolkhof, P., Joseph, A., Pieper, A., Kimmeskamp-Kirschbaum, N., Ruilope, L. M. & Mineralocorticoid Receptor Antagonist Tolerability Study–Diabetic Nephropathy (ARTS-DN) Study Group, 1 Sep 2015, In : JAMA - Journal of the American Medical Association. 314, 9, p. 884-94 11 p.

Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides

Schanstra, J. P., Zürbig, P., Alkhalaf, A., Argilés, A., Bakker, S. J. L., Beige, J., Bilo, H. J. G., Chatzikyrkou, C., Dakna, M., Dawson, J., Delles, C., Haller, H., Haubitz, M., Husi, H., Jankowski, J., Jerums, G., Kleefstra, N., Kuznetsova, T., Maahs, D. M., Menne, J., Mullen, W., Ortiz, A., Persson, F., Rossing, P., Ruggenenti, P., Rychlik, I., Serra, A. L., Siwy, J., Snell-Bergeon, J. K., Spasovski, G., Staessen, J. A., Vlahou, A., Mischak, H. & Vanholder, R., Aug 2015, In : Journal of the American Society of Nephrology : JASN. 26, 8, p. 1999-2010 12 p.

Genetic risk factors affecting mitochondrial function are associated with kidney disease in people with Type 1 diabetes

Swan, E. J., Salem, R. M., Sandholm, N., Tarnow, L., Rossing, P., Lajer, M., Groop, P. H., Maxwell, A. P., McKnight, A. J. & GENIE Consortium, Aug 2015, In : Diabetic Medicine Online. 32, 8, p. 1104-9 6 p.

Diabetic kidney disease

Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P-H. & Cooper, M. E., 30 Jul 2015, In : Nature reviews. Disease primers. 1, p. 15018

Diagnosis and treatment of early renal disease in patients with type 2 diabetes mellitus: what are the clinical needs?

Mann, J. F. E., Rossing, P., Wiȩcek, A., Rosivall, L., Mark, P. B. & Mayer, G., 24 Jul 2015, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 30 Suppl 4, p. iv1-5

Prognostic clinical and molecular biomarkers of renal disease in type 2 diabetes

Pena, M. J., de Zeeuw, D., Mischak, H., Jankowski, J., Oberbauer, R., Woloszczuk, W., Benner, J., Dallmann, G., Mayer, B., Mayer, G., Rossing, P. & Lambers Heerspink, H. J., 24 Jul 2015, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 30 Suppl 4, p. iv86-95

Glucagon-like peptide 1 receptor agonist (GLP-1 RA): long-term effect on kidney function in patients with type 2 diabetes

von Scholten, B. J., Hansen, T. W., Goetze, J. P., Persson, F. & Rossing, P., Jul 2015, In : Journal of Diabetes and its Complications. 29, 5, p. 670-4 5 p.

Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes

Brott, D. A., Furlong, S. T., Adler, S. H., Hainer, J. W., Arani, R. B., Pinches, M., Rossing, P., Chaturvedi, N. & DIRECT Programme Steering Committee, 22 Jun 2015, In : Drug Design, Development and Therapy. 9, p. 3191-8 8 p.

IGFBP-4 fragments as markers of cardiovascular mortality in type 1 diabetes patients with and without nephropathy

Hjortebjerg, R., Tarnow, L., Jorsal, A., Parving, H-H. D., Rossing, P., Bjerre, M. & Frystyk, J., 5 Jun 2015, In : The Journal of clinical endocrinology and metabolism. 100, 8, p. 3032-40

Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes

Theilade, S., Hansen, T. W., Goetze, J. P. & Rossing, P., Jun 2015, In : American Journal of Hypertension. 28, 6, p. 772-9 8 p.

Identification of possible adverse drug reactions in clinical notes: The case of glucose-lowering medicines

Warrer, P., Jensen, P. B., Aagaard, L., Jensen, L. J., Brunak, S., Krag, M. H., Rossing, P., Almdal, T., Andersen, H. U. & Hansen, E. H., 20 May 2015, In : Journal of Research in Pharmacy Practice. 4, 2, p. 64-72 9 p.

The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers

Schievink, B., de Zeeuw, D., Parving, H-H., Rossing, P. & Lambers Heerspink, H. J., 14 Apr 2015, In : British Journal of Clinical Pharmacology. 80, 4, p. 678-86

Global Longitudinal Strain Is Not Impaired in Type 1 Diabetes Patients Without Albuminuria: The Thousand & 1 Study

Jensen, M. T., Sogaard, P., Andersen, H. U., Bech, J., Fritz Hansen, T., Biering-Sørensen, T., Jørgensen, P. G., Galatius, S., Madsen, J. K., Rossing, P. & Jensen, J. S., Apr 2015, In : JACC. Cardiovascular imaging. 8, 4, p. 400-10 11 p.

Pulse pressure is not an independent predictor of outcome in type 2 diabetes patients with chronic kidney disease and anemia-the Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)

Theilade, S., Claggett, B., Hansen, T. W., Skali, H., Lewis, E. F., Solomon, S. D., Parving, H-H., Pfeffer, M., McMurray, J. J. & Rossing, P., 26 Mar 2015, In : Journal of Hypertension. 30, p. 46-52

Soluble urokinase plasminogen activator receptor levels are elevated and associated with complications in patients with type 1 diabetes

Theilade, S., Lyngbaek, S., Hansen, T. W., Eugen-Olsen, J., Fenger, M., Rossing, P. & Jeppesen, J. L., Mar 2015, In : Journal of Internal Medicine. 277, 3, p. 362-71 10 p.

SORBS1 gene, a new candidate for diabetic nephropathy: results from a multi-stage genome-wide association study in patients with type 1 diabetes

Germain, M., Pezzolesi, M. G., Sandholm, N., McKnight, A. J., Susztak, K., Lajer, M., Forsblom, C., Marre, M., Parving, H-H. D., Rossing, P., Toppila, I., Skupien, J., Roussel, R., Ko, Y-A., Ledo, N., Folkersen, L., Civelek, M., Maxwell, A. P., Tregouet, D-A., Groop, P-H., Tarnow, L. & Hadjadj, S., Mar 2015, In : Diabetologia. 58, 3, p. 543-8 6 p.

Time course and mechanisms of the anti-hypertensive and renal effects of liraglutide treatment

von Scholten, B. J., Lajer, M., Goetze, J. P., Persson, F. & Rossing, P., Mar 2015, In : Diabetic Medicine. 32, 3, p. 343-52 10 p.

Vitamin D analogue therapy, cardiovascular risk and kidney function in people with Type 1 diabetes mellitus and diabetic nephropathy: a randomized trial

Joergensen, C., Tarnow, L., Goetze, J. P. & Rossing, P., Mar 2015, In : Diabetic Medicine Online. 32, 3, p. 374-81 8 p.

Diabetic nephropathy in 2014: Improved cardiorenal prognosis in diabetic nephropathy

Parving, H-H. & Rossing, P., Feb 2015, In : Nature Reviews Nephrology. 11, 2, p. 68-70 3 p.

Improved prognosis of diabetic nephropathy in type 1 diabetes

Andrésdóttir, G., Jensen, M. L., Carstensen, B., Parving, H-H., Hovind, P., Hansen, T. W. & Rossing, P., Feb 2015, In : Kidney International. 87, 2, p. 417-26 10 p.

Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: a randomised double-blind placebo-controlled study

Hove, K. D., Brøns, C., Færch, K., Lund, S. S., Rossing, P. & Vaag, A., Jan 2015, In : European journal of endocrinology / European Federation of Endocrine Societies. 172, 1, p. 11-20 10 p.

Microalbuminuria: A parameter that has changed diabetes care

Parving, H-H., Persson, F. & Rossing, P., Jan 2015, In : Diabetes Research and Clinical Practice. 107, 1, p. 1-8 8 p.

Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetes

von Scholten, B. J., Reinhard, H., Hansen, T. W., Lindhardt, M., Petersen, C. L., Wiinberg, N., Hansen, P. R., Parving, H-H., Jacobsen, P. K. & Rossing, P., 2015, In : Cardiovascular Diabetology. 14, p. 59

Elevated Urinary Connective Tissue Growth Factor in Diabetic Nephropathy Is Caused by Local Production and Tubular Dysfunction

Gerritsen, K. G. F., Leeuwis, J. W., Koeners, M. P., Bakker, S. J. L., van Oeveren, W., Aten, J., Tarnow, L., Rossing, P., Wetzels, J. F. M., Joles, J. A., Kok, R. J., Goldschmeding, R. & Nguyen, T. Q., 2015, In : Journal of Diabetes Research. 2015, p. 539787

Pulse wave reflection is associated with diabetes duration, albuminuria and cardiovascular disease in type 1 diabetes

Theilade, S., Lajer, M., Hansen, T. W. & Rossing, P., Dec 2014, In : Acta Diabetologica. 51, 6, p. 973-80 8 p.

Treatment with continuous subcutaneous insulin infusion is associated with lower arterial stiffness

Vestergaard Rosenlund, S., Theilade, S., Hansen, T. W., Andersen, S. & Rossing, P., Dec 2014, In : Acta Diabetologica. 51, 6, p. 955-62 8 p.

Association of the pattern recognition molecule H-ficolin with incident microalbuminuria in an inception cohort of newly diagnosed type 1 diabetic patients: an 18 year follow-up study

Østergaard, J. A., Thiel, S., Hovind, P., Holt, C. B., Parving, H-H., Flyvbjerg, A., Rossing, P. & Hansen, T. K., Oct 2014, In : Diabetologia. 57, 10, p. 2201-7 7 p.

Central hemodynamics are associated with cardiovascular disease and albuminuria in type 1 diabetes

Theilade, S., Hansen, T. W. & Rossing, P., Sep 2014, In : American Journal of Hypertension. 27, 9, p. 1152-9 8 p.

Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus

Pena, M. J., Lambers Heerspink, H. J., Hellemons, M. E., Friedrich, T., Dallmann, G., Lajer, M., Bakker, S. J. L., Gansevoort, R. T., Rossing, P., de Zeeuw, D. & Roscioni, S. S., Sep 2014, In : Diabetic Medicine Online. 31, 9, p. 1138-47 10 p.

Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy

Siwy, J., Schanstra, J. P., Argilés, A., Bakker, S. J. L., Beige, J., Boucek, P., Brand, K., Delles, C., Duranton, F., Fernandez-Fernandez, B., Jankowski, M-L., Al Khatib, M., Kunt, T., Lajer, M. S., Lichtinghagen, R., Lindhardt, M., Maahs, D. M., Mischak, H., Mullen, W., Navis, G., Noutsou, M., Ortiz, A., Persson, F., Petrie, J. R., Roob, J. M., Rossing, P., Ruggenenti, P., Rychlik, I., Serra, A. L., Snell-Bergeon, J. K., Spasovski, G., Stojceva-Taneva, O., Trillini, M., von der Leyen, H., Winklhofer-Roob, B. M., Zürbig, P. & Jankowski, J., Aug 2014, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 29, 8, p. 1563-70 8 p.

Glomerular filtration rate estimation using cystatin C alone or combined with creatinine as a confirmatory test

Fan, L., Inker, L. A., Rossert, J., Froissart, M., Rossing, P., Mauer, M. & Levey, A. S., Jun 2014, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 29, 6, p. 1195-203 9 p.

Improved survival and renal prognosis of patients with type 2 diabetes and nephropathy with improved control of risk factors

Andrésdóttir, G., Jensen, M., Carstensen, B., Parving, H-H., Rossing, K., Hansen, T. W. & Rossing, P., Jun 2014, In : Diabetes Care. 37, 6, p. 1660-7 8 p.

Urinary alpha- and pi-glutathione s-transferases in adult patients with type 1 diabetes

von Scholten, B. J., Theilade, S., Lajer, M. & Rossing, P., May 2014, In : Nephron. 4, 2, p. 127-33 7 p.

Prevalence of systolic and diastolic dysfunction in patients with type 1 diabetes without known heart disease: the Thousand & 1 Study

Jensen, M. T., Sogaard, P., Andersen, H. U., Bech, J., Hansen, T. F., Galatius, S., Jørgensen, P. G., Biering-Sørensen, T., Møgelvang, R., Rossing, P. & Jensen, J. S., Apr 2014, In : Diabetologia. 57, 4, p. 672-80 9 p.

Sequential RAAS blockade: is it worth the risk?

Persson, F. & Rossing, P., Mar 2014, In : Advances in Chronic Kidney Disease. 21, 2, p. 159-65 7 p.

SVAR: Det nytter at diagnosticere diabetes tidligt

Rossing, P., 1 Jan 2014, In : Ugeskrift for Laeger. 176, 21

Cause-specific mortality according to urine albumin creatinine ratio in the general population

Skaaby, T., Husemoen, L. L. N., Ahluwalia, T. S., Rossing, P., Jørgensen, T., Thuesen, B. H., Pisinger, C., Rasmussen, K. & Linneberg, A., 2014, In : P L o S One. 9, 3, p. e93212

Rationale, design, and baseline characteristics of ARTS-DN: a randomized study to assess the safety and efficacy of finerenone in patients with type 2 diabetes mellitus and a clinical diagnosis of diabetic nephropathy

Ruilope, L. M., Agarwal, R., Chan, J. C., Cooper, M. E., Gansevoort, R. T., Haller, H., Remuzzi, G., Rossing, P., Schmieder, R. E., Nowack, C., Ferreira, A. C., Pieper, A., Kimmeskamp-Kirschbaum, N. & Bakris, G. L., 2014, In : American Journal of Nephrology. 40, 6, p. 572-81 10 p.

Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia

Bello, N. A., Pfeffer, M. A., Skali, H., McGill, J. B., Rossert, J., Olson, K. A., Weinrauch, L., Cooper, M. E., de Zeeuw, D., Rossing, P., McMurray, J. J. V. & Solomon, S. D., 2014, In : BMJ open diabetes research & care. 2, 1, p. e000011

Can ADAMTS13 lead us to the paradise of personalized medicine?

Rossing, P. & Lajer, M., Oct 2013, In : Diabetes. 62, 10, p. 3331-2 2 p.

Improving peptide relative quantification in MALDI-TOF MS for biomarker assessment

Albalat, A., Stalmach, A., Bitsika, V., Siwy, J., Schanstra, J. P., Petropoulos, A. D., Vlahou, A., Jankowski, J., Persson, F., Rossing, P., Jaskolla, T. W., Mischak, H. & Husi, H., Oct 2013, In : Proteomics. 13, 20, p. 2967-75 9 p.

Clinical use of estimated glomerular filtration rate for evaluation of kidney function

Broberg, B., Lindhardt, M., Rossing, P., Ibsen, H., Persson, F. I. & Rasmussen, K., 30 Sep 2013, In : Ugeskrift for Laeger. 175, 40, p. 2333-2336 4 p.

Diabetes mellitus, hypertension and albuminuria in rural Zambia: a hospital-based survey

Rasmussen, J. B., Thomsen, J. A., Rossing, P., Parkinson, S., Christensen, D. L. & Bygbjerg, I. C., Sep 2013, In : Tropical medicine & international health : TM & IH. 18, 9, p. 1080-1084 5 p.

24-hour central aortic systolic pressure and 24-hour central pulse pressure are related to diabetic complications in type 1 diabetes - a cross-sectional study

Theilade, S., Lajer, M. S., Hansen, T. W., Joergensen, C., Persson, F., Andrésdottir, G., Reinhard, H., Nielsen, S. E., Lacy, P., Williams, B. & Rossing, P., 27 Aug 2013, In : Cardiovascular Diabetology. 12, p. 122

Urinary adiponectin excretion rises with increasing albuminuria in type 1 diabetes

Jorsal, A., Petersen, E. H., Tarnow, L., Hess, G., Zdunek, D., Frystyk, J., Flyvbjerg, A., Lajer, M. & Rossing, P., 24 Aug 2013, In : Journal of Diabetes and its Complications. 27, 6, p. 604-8 5 p.

Uric acid lowering to prevent kidney function loss in diabetes: the preventing early renal function loss (PERL) allopurinol study

Maahs, D. M., Caramori, L., Cherney, D. Z. I., Galecki, A. T., Gao, C., Jalal, D., Perkins, B. A., Pop-Busui, R., Rossing, P., Mauer, M., Doria, A. & PERL Consortium, Aug 2013, In : Current Diabetes Reports. 13, 4, p. 550-9 10 p.

Urinary renin and angiotensinogen in type 2 diabetes: added value beyond urinary albumin?

Persson, F., Lu, X., Rossing, P., Garrelds, I. M., Danser, A. H. J. & Parving, H-H., Aug 2013, In : Journal of Hypertension. 31, 8, p. 1646-52 7 p.

Tonometric devices for central aortic systolic pressure measurements in patients with type 1 diabetes: comparison of the BPro and SphygmoCor devices

Theilade, S., Hansen, T. W., Joergensen, C., Lajer, M. & Rossing, P., Jun 2013, In : Blood Pressure Monitoring. 18, 3, p. 156-60 5 p.

Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes

Andrésdóttir, G., Bakker, S. J. L., Hansen, H. P., Parving, H-H. & Rossing, P., May 2013, In : Diabetic Medicine Online. 30, 5, p. 563-6 4 p.

Arterial stiffness is associated with cardiovascular, renal, retinal, and autonomic disease in type 1 diabetes

Theilade, S., Lajer, M. S., Persson, F., Joergensen, C. & Rossing, P., Mar 2013, In : Diabetes Care. 36, 3, p. 715-21 7 p.

Diabetic nephropathy: Could problems with bardoxolone methyl have been predicted?

Rossing, P., Mar 2013, In : Nature Reviews Nephrology. 9, 3, p. 128-30 3 p.

A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus

Roscioni, S. S., de Zeeuw, D., Hellemons, M. E., Mischak, H., Zürbig, P., Bakker, S. J. L., Gansevoort, R. T., Reinhard, H., Persson, F., Lajer, M., Rossing, P. & Lambers Heerspink, H. J., Feb 2013, In : Diabetologia. 56, 2, p. 259-67 9 p.

Common variant in the HMGA2 gene increases susceptibility to nephropathy in patients with type 2 diabetes

Alkayyali, S., Lajer, M., Deshmukh, H., Ahlqvist, E., Colhoun, H., Isomaa, B., Rossing, P., Groop, L. & Lyssenko, V., Feb 2013, In : Diabetologia. 56, 2, p. 323-9 7 p.

RNA oxidation and albuminuria in type 1 diabetes patients

Broedbaek, K., Andersen, J. T., Jimenez-Solem, E., Petersen, M., Lajer, M., Henriksen, T., Weimann, A., Parving, H. H., Rossing, P. & Poulsen, H. E., 1 Jan 2013, In : Cardiovascular Endocrinology. 2, 4, p. 103-105 3 p.

Diabetes: Effect of vitamin D on diabetic kidney disease in T1DM

Rossing, P. & Joergensen, C., Jan 2013, In : Nature reviews. Endocrinology. 9, 1, p. 6-7 2 p.

Direct renin inhibition in chronic kidney disease

Persson, F., Rossing, P. & Parving, H-H., 2013, In : British Journal of Clinical Pharmacology. 76, 4, p. 580-86

Levels of NT-proBNP, markers of low-grade inflammation, and endothelial dysfunction during spironolactone treatment in patients with diabetic kidney disease

Nielsen, S., Schjoedt, K. J., Rossing, K., Persson, F., Schalkwijk, C. G., Stehouwer, C. DA., Parving, H-H. & Rossing, P., 2013, In : Journal of the Renin-Angiotensin-Aldosterone System. 14, 2, p. 161-6

Vitamin D status and 5-year changes in urine albumin creatinine ratio and parathyroid hormone in a general population

Skaaby, T., Husemoen, L. L. N., Pisinger, C., Jørgensen, T., Thuesen, B. H., Rasmussen, K., Fenger, M., Rossing, P. & Linneberg, A., 2013, In : Endocrine. 44, 2, p. 473-80

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

Fox, C. S., Matsushita, K., Woodward, M., Bilo, H. J. G., Chalmers, J., Heerspink, H. J. L., Lee, B. J., Perkins, R. M., Rossing, P., Sairenchi, T., Tonelli, M., Vassalotti, J. A., Yamagishi, K., Coresh, J., de Jong, P. E., Wen, C-P., Nelson, R. G. & Chronic Kidney Disease Prognosis Consortium, 10 Nov 2012, In : Lancet (London, England). 380, 9854, p. 1662-73 12 p.

Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis

Mahmoodi, B. K., Matsushita, K., Woodward, M., Blankestijn, P. J., Cirillo, M., Ohkubo, T., Rossing, P., Sarnak, M. J., Stengel, B., Yamagishi, K., Yamashita, K., Zhang, L., Coresh, J., de Jong, P. E., Astor, B. C. & Chronic Kidney Disease Prognosis Consortium, 10 Nov 2012, In : Lancet (London, England). 380, 9854, p. 1649-61 13 p.

Kvalitetssikring i behandling af en folkesygdom: diabetes

Rossing, P., Adolphsen, H., Stenkær Ravnkilde, S., Cerqueira, C. & Friborg, S., 15 Oct 2012, In : Ugeskrift for Laeger. 174, 42, p. 2551

Plasma NT-proBNP and white matter hyperintensities in type 2 diabetic patients

Reinhard, H., Garde, E., Skimminge, A., Akeson, P., Ramsøy, T., Winther, K., Parving, H-H., Rossing, P. & Jacobsen, P. K., 3 Oct 2012, In : Cardiovascular Diabetology. 11, 1, 9 p.

Discrepancy between tonometric ambulatory and cuff-based office blood pressure measurements in patients with type 1 diabetes

Theilade, S., Lajer, M. S., Joergensen, C., Persson, F. & Rossing, P., Oct 2012, In : Journal of Clinical Hypertension. 14, 10, p. 686-93 8 p.

Nyresygdom ved type 2-diabetes

Persson, F. & Rossing, P., 10 Sep 2012, In : Ugeskrift for Laeger. 174, 37, p. 2150-4 5 p.

Implementation of proteomic biomarkers: making it work

Mischak, H., Ioannidis, J. P. A., Argilés, A., Attwood, T. K., Bongcam-Rudloff, E., Broenstrup, M., Charonis, A., Chrousos, G. P., Delles, C., Dominiczak, A., Dylag, T., Ehrich, J. H. H., Egido, J., Findeisen, P., Jankowski, J., Johnson, R. W., Julien, B. A., Lankisch, T., Leung, H. Y., Maahs, D. M., Magni, F., Manns, M. P., Manolis, E., Mayer, G., Navis, G., Novak, J., Ortiz, A., Persson, F., Peter, K., Riese, H. H., Rossing, P., Sattar, N., Spasovski, G., Thongboonkerd, V., Vanholder, R., Schanstra, J. P. & Vlahou, A., Sep 2012, In : European Journal of Clinical Investigation. 42, 9, p. 1027-36 10 p.

Ambulatory tonometric blood pressure measurements in patients with diabetes

Theilade, S., Joergensen, C., Persson, F., Lajer, M. S. & Rossing, P., Jun 2012, In : Diabetes Technology and Therapeutics. 14, 6, p. 453-6 4 p.

Assessment of kidney function: UACR--two risk markers or a 24 h collection in a minute?

Rossing, P., 8 May 2012, In : Nature Reviews Nephrology. 8, 6, p. 320-1 2 p.

The authors reply

Nielsen, S. E. & Rossing, P., 1 Apr 2012, In : Kidney International. 81, 7, 1 p.

Impact of aliskiren treatment on urinary aldosterone levels in patients with type 2 diabetes and nephropathy: an AVOID substudy

Persson, F., Lewis, J. B., Lewis, E. J., Rossing, P., Hollenberg, N. K. & Hans-Henrik, P., Mar 2012, In : Journal of the renin-angiotensin-aldosterone system : JRAAS. 13, 1, p. 118-21 4 p.

Cardiovascular autonomic neuropathy and subclinical cardiovascular disease in normoalbuminuric type 1 diabetic patients

Mogensen, U. M., Jensen, T., Køber, L., Kelbæk, H., Mathiesen, A. S., Dixen, U., Rossing, P., Hilsted, J. & Kofoed, K. F., 2012, In : Diabetes. 61, 7, p. 1822-30 9 p.

Effect of Irbesartan treatment on plasma and urinary markers of protein damage in patients with type 2 diabetes and microalbuminuria

Rabbani, N., Adaikalakoteswari, A., Rossing, K., Rossing, P., Tarnow, L., Parving, H-H. & Thornalley, P. J., 2012, In : Amino Acids. 42, 5, p. 1627-39 13 p.

High YKL-40 levels predict mortality in patients with type 2 diabetes

Persson, F., Rathcke, C. N., Gall, M-A., Parving, H-H., Vestergaard, H. & Rossing, P., 2012, In : Diabetes Research and Clinical Practice. 96, 1, p. 84-9 6 p.

Impact of glycaemic control on the effect of direct renin inhibition in the AVOID study

Persson, F., Lewis, J. B., Lewis, E. J., Rossing, P., Hollenberg, N. K. & Parving, H-H., 2012, In : Journal of the Renin-Angiotensin-Aldosterone System. 13, 2, p. 250-3 4 p.

Kvalitetssikring i forbindelse med en folkesygdom: diabetes

Rossing, P., Adolphsen, H., Ravnkilde, SS., Cerqueira, C. & Friborg, S., 2012, In : Ugeskrift for Laeger. 174, 42, p. 2551

New susceptibility loci associated with kidney disease in type 1 diabetes

Sandholm, N., Salem, R. M., McKnight, A. J., Brennan, E. P., Forsblom, C., Isakova, T., McKay, G. J., Williams, W. W., Sadlier, D. M., Mäkinen, V-P., Swan, E. J., Palmer, C., Boright, A. P., Ahlqvist, E., Deshmukh, H. A., Keller, B. J., Huang, H., Ahola, A. J., Fagerholm, E., Gordin, D., Harjutsalo, V., He, B., Heikkilä, O., Hietala, K., Kytö, J., Lahermo, P., Lehto, M., Lithovius, R., Osterholm, A-M., Parkkonen, M., Pitkäniemi, J., Rosengård-Bärlund, M., Saraheimo, M., Sarti, C., Söderlund, J., Soro-Paavonen, A., Syreeni, A., Thorn, L. M., Tikkanen, H., Tolonen, N., Tryggvason, K., Tuomilehto, J., Wadén, J., Gill, G. V., Prior, S., Guiducci, C., Mirel, D. B., Parving, H-H., Rossing, P., Tarnow, L. & DCCT/EDIC Research Group, 2012, In : P L o S Genetics. 8, 9, p. e1002921

NT-proBNP, echocardiographic abnormalities and subclinical coronary artery disease in high risk type 2 diabetic patients

Reinhard, H., Hansen, P. R., Wiinberg, N., Kjær, A., Petersen, C. L., Winther, K., Parving, H-H., Rossing, P. & Jacobsen, P. K., 2012, In : Cardiovascular Diabetology. 11, p. 19

Serum amyloid A and C-reactive protein levels may predict microalbuminuria and macroalbuminuria in newly diagnosed type 1 diabetic patients

Overgaard, A. J., McGuire, J. N., Hovind, P., Parving, H-H., Rossing, P. & Pociot, F., 2012, In : Journal of Diabetes and its Complications. 27, 1, p. 59-63 5 p.

Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study

Nielsen, S. E., Persson, F., Frandsen, E., Sugaya, T., Hess, G., Zdunek, D., Shjoedt, K. J., Parving, H-H. & Rossing, P., 2012, In : Diabetic Medicine. 29, 8, p. e184-90

The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP

Nielsen, S., Rossing, K., Hess, G., Zdunek, D., Jensen, B. R., Parving, H-H. & Rossing, P., 2012, In : Scandinavian Journal of Clinical & Laboratory Investigation. 72, 2, p. 137-42 6 p.

Tubular markers are associated with decline in kidney function in proteinuric type 2 diabetic patients

Nielsen, S., Reinhard, H., Zdunek, D., Hess, G., Gutiérrez, O. M., Wolf, M., Parving, H-H., Jacobsen, P. K. & Rossing, P., 2012, In : Diabetes Research and Clinical Practice. 97, 1, p. 71-6 6 p.

Urinary proteomics for early diagnosis in diabetic nephropathy

Zürbig, P., Jerums, G., Hovind, P., Macisaac, R. J., Mischak, H., Nielsen, S., Panagiotopoulos, S., Persson, F. & Rossing, P., 2012, In : Diabetes. 61, 12, p. 3304-13 10 p.

Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate

Joergensen, C., Reinhard, H., Schmedes, A., Hansen, P. R., Wiinberg, N., Petersen, C. L., Winther, K., Parving, H-H., Jacobsen, P. K. & Rossing, P., 2012, In : Diabetes Care. 35, 1, p. 168-72 5 p.

Experimental testing of skin reactions to insulin detemir in diabetes patients naïve to insulin detemir

O'goshi, K., Serup, J., Blaaholm, B., Thomsen, H. K., Rossing, P. & Tarnow, L., Nov 2011, In : Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI). 17, 4, p. 411-9 9 p.

Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts

Astor, B. C., Matsushita, K., Gansevoort, R. T., van der Velde, M., Woodward, M., Levey, A. S., Jong, P. E. D., Coresh, J., Astor, B. C., Matsushita, K., Gansevoort, R. T., van der Velde, M., Woodward, M., Levey, A. S., de Jong, P. E., Coresh, J., El-Nahas, M., Eckardt, K-U., Kasiske, B. L., Wright, J., Appel, L., Greene, T., Levin, A., Djurdjev, O., Wheeler, D. C., Landray, M. J., Townend, J. N., Emberson, J., Clark, L. E., Macleod, A., Marks, A., Ali, T., Fluck, N., Prescott, G., Smith, D. H., Weinstein, J. R., Johnson, E. S., Thorp, M. L., Wetzels, J. F., Blankestijn, P. J., van Zuilen, A. D., Menon, V., Sarnak, M., Beck, G., Kronenberg, F., Kollerits, B., Froissart, M., Stengel, B., Rossing, P., Parving, H-H. & Chronic Kidney Disease Prognosis Consortium, Jun 2011, In : Kidney International. 79, 12, p. 1331-40 10 p.

Long-Term Effects of Irbesartan Treatment and Smoking on Nucleic Acid Oxidation in Patients With Type 2 Diabetes and Microalbuminuria: An Irbesartan in Patients With Type 2 Diabetes and Microalbuminuria (IRMA 2) substudy

Broedbaek, K., Henriksen, T., Weimann, A., Petersen, M., Andersen, J. T., Afzal, S., Jimenez-Solem, E., Persson, F., Parving, H-H., Rossing, P. & Poulsen, H. E., 1 May 2011, In : Diabetes Care. 34, 5, p. 1192-8 7 p.

Vitamin D levels, microvascular complications, and mortality in type 1 diabetes

Joergensen, C., Hovind, P., Schmedes, A., Parving, H-H. & Rossing, P., 1 May 2011, In : Diabetes Care. 34, 5, p. 1081-5 5 p.

Irbesartan treatment does not influence plasma levels of the advanced glycation end products N{varepsilon}(1-carboxymethyl)lysine and N{varepsilon}(1-carboxyethyl)lysine in patients with type 2 diabetes and microalbuminuria. A randomized controlled trial

Engelen, L., Persson, F., Ferreira, I., Rossing, P., Hovind, P., Teerlink, T., Stehouwer, C. D., Parving, H-H. & Schalkwijk, C. G., 8 Mar 2011, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 26, 11, p. 3573-3577

Need for better diabetes treatment for improved renal outcome

Rossing, P. & de Zeeuw, D., Mar 2011, In : Kidney International, Supplement. 120, p. S28-32

Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study

Nin, J. W., Jorsal, A., Ferreira, I., Schalkwijk, C. G., Prins, M. H., Parving, H-H., Tarnow, L., Rossing, P. & Stehouwer, C. D., Feb 2011, In : Diabetes Care. 34, 2, p. 442-7 6 p.

Serum uric acid as a new player in the development of diabetic nephropathy

Hovind, P., Rossing, P., Johnson, R. J. & Parving, H-H., 1 Jan 2011, In : Journal of Renal Nutrition. 21, 1, p. 124-7 4 p.

Aliskiren in combination with losartan reduces albuminuria independent of baseline blood pressure in patients with type 2 diabetes and nephropathy

Persson, F., Lewis, J. B., Lewis, E. J., Rossing, P., Hollenberg, N. K. & Parving, H-H., 2011, In : American Society of Nephrology. Clinical Journal. 6, 5, p. 1025-31 7 p.

Diabetic Nephropathy

Parving, H-H. D., Mauer, M., Fioretto, P., Rossing, P. & Ritz, E., 2011, Brenner and Rector's The Kidney. Taal et al., M. W. (ed.). 9. ed. W. B. Saunders Company, p. 1411

Elevated NT-proBNP and coronary calcium score in relation to coronary artery disease in asymptomatic type 2 diabetic patients with elevated urinary albumin excretion rate

Reinhard, H., Hansen, P. R., Persson, F., Tarnow, L., Wiinberg, N., Kjær, A., Petersen, C. L., Winther, K., Parving, H-H., Rossing, P. & Jacobsen, P. K., 2011, In : Nephrology, Dialysis, Transplantation. 26, 10, p. 3242-9 8 p.

Endothelial progenitor cells in long-standing asymptomatic type 1 diabetic patients with or without diabetic nephropathy

Reinhard, H., Jacobsen, P. K., Lajer, M. S., Tarnow, L., Bording Astrup, A. S., Kim, W. Y., Pedersen, N., Billestrup, N., Mandrup-Poulsen, T., Parving, H-H. & Rossing, P., 2011, In : Nephron Clinical Practice. 118, 3, p. c309-14 6 p.

Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes

Cangemi, C., Skov, V., Poulsen, M. K., Funder, J. A., Twal, W. O., Gall, M-A., Hjortdal, V. E., Jespersen, M. L., Kruse, T. A., Aagard, J., Parving, H-H., Knudsen, S., Høilund-Carlsen, P-F., Rossing, P., Henriksen, J. E., Argraves, W. S. & Rasmussen, L. M., 2011, In : Clinical Chemistry (Washington, DC). 57, 11, p. 1556-65 10 p.

initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial

Hellemons, M. E., Persson, F., Bakker, S. J. L., Rossing, P., Parving, H-H., De Zeeuw, D. & Lambers Heerspink, H. J., 2011, In : Diabetes Care. 34, 9, p. 2078-83 6 p.

NT-proBNP levels, atherosclerosis and vascular function in asymptomatic type 2 diabetic patients with microalbuminuria: peripheral reactive hyperaemia index but not NT-proBNP is an independent predictor of coronary atherosclerosis

Reinhard, H., Wiinberg, N., Hansen, P. R., Kjær, A., Petersen, C. L., Winther, K., Parving, H-H., Rossing, P. & Jacobsen, P. K., 2011, In : Cardiovascular Diabetology. 10, p. 71

Omics-bioinformatics in the context of clinical data

Mayer, G., Heinze, G., Mischak, H., Hellemons, M. E., Heerspink, H. J. L., Bakker, S. J. L., de Zeeuw, D., Haiduk, M., Rossing, P. & Oberbauer, R., 2011, In : Methods in molecular biology (Clifton, N.J.). 719, p. 479-97 19 p.

Osteoprotegerin and coronary artery disease in type 2 diabetic patients with microalbuminuria

Reinhard, H., Nybo, M., Hansen, P. R., Wiinberg, N., Kjær, A., Petersen, C. L., Winther, K., Parving, H-H., Rasmussen, L. M., Rossing, P. & Jacobsen, P. K., 2011, In : Cardiovascular Diabetology. 10, p. 70

The CTGF -945GC polymorphism is not associated with plasma CTGF and does not predict nephropathy or outcome in type 1 diabetes

Dendooven, A., Nguyen, T. Q., Brosens, L., Li, D., Tarnow, L., Parving, H-H., Rossing, P. & Goldschmeding, R., 2011, In : Journal of Negative Results in BioMedicine. 10, p. 4

Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy

Nielsen, S. E., Andersen, S., Zdunek, D., Hess, G., Parving, H-H. & Rossing, P., 2011, In : Kidney International. 79, 10, p. 1113-8 6 p.

Urinary Neutrophil Gelatinase-Associated Lipocalin and Progression of Diabetic Nephropathy in Type 1 Diabetic Patients in a Four-Year Follow-Up Study

Nielsen, S. E., Hansen, H. P., Jensen, B. R., Parving, H-H. & Rossing, P., 15 Dec 2010, In : Nephron Clinical Practice. 118, 2, p. c130-c135

Osteoprotegerin and mortality in type 2 diabetic patients

Reinhard, H., Lajer, M. S., Gall, M-A., Tarnow, L., Parving, H-H., Rasmussen, L. M. & Rossing, P., 1 Dec 2010, In : Diabetes Care. 33, 12, p. 2561-6 6 p.

Quantitative iTRAQ-Based Proteomic Identification of Candidate Biomarkers for Diabetic Nephropathy in Plasma of Type 1 Diabetic Patients

Overgaard, A. J., Thingholm, T. E., Larsen, M. R., Tarnow, L., Rossing, P., McGuire, J. N. & Pociot, F., Dec 2010, In : Clinical Proteomics. 6, 4, p. 105-114 10 p.

Impact of baseline renal function on the efficacy and safety of aliskiren added to losartan in patients with type 2 diabetes and nephropathy

Persson, F., Lewis, J. B., Lewis, E. J., Rossing, P., Hollenberg, N. K., Parving, H-H. & AVOID Study Investigators, 1 Nov 2010, In : Diabetes Care. 33, 11, p. 2304-9 6 p.

Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals

Delles, C., Schiffer, E., von Zur Muhlen, C., Peter, K., Rossing, P., Parving, H-H., Dymott, J. A., Neisius, U., Zimmerli, L. U., Snell-Bergeon, J. K., Maahs, D. M., Schmieder, R. E., Mischak, H. & Dominiczak, A. F., 1 Nov 2010, In : Journal of Hypertension. 28, 11, p. 2316-22 7 p.

Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy

Alkhalaf, A., Zürbig, P., Bakker, S. J. L., Bilo, H. J. G., Cerna, M., Fischer, C., Fuchs, S., Janssen, B., Medek, K., Mischak, H., Roob, J. M., Rossing, K., Rossing, P., Rychlík, I., Sourij, H., Tiran, B., Winklhofer-Roob, B. M., Navis, G. J. & PREDICTIONS Group, 20 Oct 2010, In : P L o S One. 5, 10, p. e13421

Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: An inception cohort study (Diabetes (2009) 58 (1668-1671))

Hovind, P., Rossing, P., Tarnow, L., Johnson, R. J. & Parving, H. H., 1 Oct 2010, In : Diabetes. 59, 10, 1 p.

Vitamin D levels and mortality in type 2 diabetes

Joergensen, C., Gall, M-A., Schmedes, A., Tarnow, L., Parving, H-H. & Rossing, P., 1 Oct 2010, In : Diabetes Care. 33, 10, p. 2238-43 6 p.

Urinary collagen fragments are significantly altered in diabetes: a link to pathophysiology

Maahs, D. M., Siwy, J., Argilés, A., Cerna, M., Delles, C., Dominiczak, A. F., Gayrard, N., Iphöfer, A., Jänsch, L., Jerums, G., Medek, K., Mischak, H., Navis, G. J., Roob, J. M., Rossing, K., Rossing, P., Rychlík, I., Schiffer, E., Schmieder, R. E., Wascher, T. C., Winklhofer-Roob, B. M., Zimmerli, L. U., Zürbig, P. & Snell-Bergeon, J. K., 28 Sep 2010, In : P L o S One. 5, 9

Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis

Hansen, H. G., Overgaard, J., Lajer, M., Hubalek, F., Højrup, P., Pedersen, L., Tarnow, L., Rossing, P., Pociot, F. & McGuire, J. N., Sep 2010, In : Proteomics - Clinical Applications. 4, 8-9, p. 697-705 9 p.

Proteomic biomarkers in diabetic nephropathy--reality or future promise?

Mischak, H. & Rossing, P., Sep 2010, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 25, 9, p. 2843-5 3 p.

Recommendations for biomarker identification and qualification in clinical proteomics

Mischak, H., Allmaier, G., Apweiler, R., Attwood, T., Baumann, M., Benigni, A., Bennett, S. E., Bischoff, R., Bongcam-Rudloff, E., Capasso, G., Coon, J. J., D'Haese, P., Dominiczak, A. F., Dakna, M., Dihazi, H., Ehrich, J. H., Fernandez-Llama, P., Fliser, D., Frokiaer, J., Garin, J., Girolami, M., Hancock, W. S., Haubitz, M., Hochstrasser, D., Holman, R. R., Ioannidis, J. P. A., Jankowski, J., Julian, B. A., Klein, J. B., Kolch, W., Luider, T., Massy, Z., Mattes, W. B., Molina, F., Monsarrat, B., Novak, J., Peter, K., Rossing, P., Sánchez-Carbayo, M., Schanstra, J. P., Semmes, O. J., Spasovski, G., Theodorescu, D., Thongboonkerd, V., Vanholder, R., Veenstra, T. D., Weissinger, E., Yamamoto, T. & Vlahou, A., 25 Aug 2010, In : Science translational medicine. 2, 46, p. 46ps42

Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study

Nin, J. W. M., Jorsal, A., Merces Ferreira, I. M., Schalkwijk, C. G., Prins, M. H., Parving, H-H., Tarnow, L., Rossing, P. & Stehouwer, C. D. A., 1 Aug 2010, In : Diabetes. 59, 8, p. 2027-32 6 p.

Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial

Persson, F. I., Rossing, P., Reinhard, H., Juhl, T., Stehouwer, C. D. A., Schalkwijk, C., Danser, A. H. J., Boomsma, F., Frandsen, E. & Parving, H-H., 1 Aug 2010, In : Diabetologia. 53, 8, p. 1576-80 5 p.

Plasma growth differentiation factor-15 independently predicts all-cause and cardiovascular mortality as well as deterioration of kidney function in type 1 diabetic patients with nephropathy

Lajer, M. S., Jorsal, A., Tarnow, L., Parving, H-H. & Rossing, P., 1 Jul 2010, In : Diabetes Care. 33, 7, p. 1567-72 6 p.

Urinary liver-type fatty acid-binding protein predicts progression to nephropathy in type 1 diabetic patients

Nielsen, S. E., Sugaya, T., Hovind, P., Baba, T., Parving, H-H. & Rossing, P., 1 Jun 2010, In : Diabetes Care. 33, 6, p. 1320-4 5 p.

Systems biology to battle vascular disease

Dominiczak, A. F., Herget-Rosenthal, S., Delles, C., Fliser, D., Fournier, I., Graber, A., Girolami, M., Holmes, E., Lang, F., Molina, F., Nicholson, J., Remuzzi, G., Rossing, P., Rudolph, K. L., Wolkenhauer, O., Xenarios, I., Zubarev, R., Zubov, D., Vlahou, A. & Schanstra, J. P., Apr 2010, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 25, 4, p. 1019-22 4 p.

Development and validation of GFR-estimating equations using diabetes, transplant and weight

Stevens, L. A., Schmid, C. H., Zhang, Y. L., Coresh, J., Manzi, J., Landis, R., Bakoush, O., Contreras, G., Genuth, S., Klintmalm, G. B., Poggio, E., Rossing, P., Rule, A. D., Weir, M. R., Kusek, J., Greene, T. & Levey, A. S., Feb 2010, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 25, 2, p. 449-57 9 p.

Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria

Andersen, S. P., Mischak, H., Zürbig, P., Parving, H-H. & Rossing, P., 1 Jan 2010, In : B M C Nephrology. 11, p. 29

Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy

Overgaard, A. J., Hansen, H. G., Lajer, M., Pedersen, L., Tarnow, L., Rossing, P., McGuire, J. N. & Pociot, F., 2010, In : Proteome Science. 8, p. 4

Soluble CD40 ligand is elevated in type 1 diabetic nephropathy but not predictive of mortality, cardiovascular events or kidney function

Lajer, M. S., Tarnow, I., Michelson, A. D., Jorsal, A., Frelinger, A. L., Parving, H-H., Rossing, P. & Tarnow, L., 2010, In : Platelets. 21, 7, p. 525-32 8 p.

Autoregulation of glomerular filtration rate during spironolactone treatment in hypertensive patients with type 1 diabetes: a randomized crossover trial

Schjoedt, K. J., Christensen, P. K., Jorsal, A., Boomsma, F., Rossing, P. & Parving, H-H., Nov 2009, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 24, 11, p. 3343-9 7 p.

Nephropathy in type 1 diabetes is associated with increased circulating activated platelets and platelet hyperreactivity

Tarnow, I., Michelson, A. D., Barnard, M. R., Frelinger, A. L., Aasted, B., Jensen, B. R., Parving, H-H., Rossing, P. & Tarnow, L., Nov 2009, In : Platelets. 20, 7, p. 513-9 7 p.

Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes

Lund, S. S., Tarnow, L., Bording Astrup, A. S., Hovind, P., Jacobsen, P. K., Alibegovic, A. C., Parving, I., Pietraszek, L., Frandsen, M-L. F., Rossing, P., Parving, H-H. D. & Vaag, A. A., 1 Oct 2009, In : Diabetes, Obesity and Metabolism. 11, 10, p. 966-77 12 p.

Tubular and glomerular injury in diabetes and the impact of ACE inhibition

Nielsen, S. E., Sugaya, T., Tarnow, L., Lajer, M. S., Schjoedt, K. J., Astrup, A. S., Baba, T., Parving, H-H. & Rossing, P., Sep 2009, In : Diabetes Care. 32, 9, p. 1684-8 5 p.

Hypertension og diabetes mellitus

Poulsen, P. L., Hansen, K. W., Gaede, P. H. & Rossing, P., 8 Jun 2009, In : Ugeskrift for Laeger. 171, 24, p. 2031-4 4 p.

Klinisk vurdering af ekskretorisk nyrefunktion

Petersen, L. J., Birn, H., Ladefoged, S. A., Randers, E., Rehling, M., Reinholdt, B. & Rossing, P., 23 Mar 2009, In : Ugeskrift for Laeger. 171, 13, p. 1090

Klinisk vurdering af ekskretorisk nyrefunktion dansk nefrologisk selskab

Petersen, L. J., Birn, H., Ladefoged, S. A., Randers, E., Rehling, M., Reinholdt, B. & Rossing, P., 1 Mar 2009, In : Ugeskrift for Laeger. 171, 13, 1 p.

YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria

Rathcke, C. N., Persson, F., Tarnow, L., Rossing, P. & Vestergaard, H., Feb 2009, In : Diabetes Care. 32, 2, p. 323-8 6 p.

Follow-up of intensive glucose control in type 2 diabetes

Lund, S. S., Rossing, P. & Vaag, A. A., 22 Jan 2009, In : The New England journal of medicine. 360, 4, p. 416; author reply 418

Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial

Schjoedt, K. J., Astrup, A. S., Persson, F. I., Frandsen, E., Boomsma, F., Rossing, K., Tarnow, L., Rossing, P. & Parving, H-H. D., 2009, In : Diabetologia. 52, 1, p. 46-9 3 p.

Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria

Persson, F., Rossing, P., Reinhard, H., Juhl, T., Stehouwer, C. D. A., Schalkwijk, C., Danser, A. H. J., Boomsma, F., Frandsen, E. & Parving, H-H. D., 2009, In : Diabetes Care. 32, 10, p. 1873-9 6 p.

Serum uric acid as a predictor for development of diabetic nephropathy in type 1 diabetes: an inception cohort study

Hovind, P., Rossing, P., Tarnow, L., Johnson, R. J. & Parving, H-H., 2009, In : Diabetes. 58, 7, p. 1668-71 3 p.

Is renal Na+,K+-ATPase a new target for renin-angiotensin blocking agents in diabetic nephropathy?

Rossing, P., 15 Nov 2008, In : The Journal of physiology. 586, 22, p. 5283

Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy

Jorsal, A., Tarnow, L., Flyvbjerg, A., Parving, H-H., Rossing, P. & Rasmussen, L. M., Nov 2008, In : Diabetologia. 51, 11, p. 2100-7 8 p.

Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy

Jorsal, A., Tarnow, L., Frystyk, J., Lajer, M. S., Flyvbjerg, A., Parving, H-H., Vionnet, N. & Rossing, P., Sep 2008, In : Kidney International. 74, 5, p. 649-54 6 p.

Elevated levels of high-molecular-weight adiponectin in type 1 diabetes

Leth, H., Andersen, K. K., Frystyk, J., Tarnow, L., Rossing, P., Parving, H-H. & Flyvbjerg, A., Aug 2008, In : The Journal of clinical endocrinology and metabolism. 93, 8, p. 3186-91 6 p.

The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy

Rossing, K., Mischak, H., Rossing, P., Schanstra, J. P., Wiseman, A. & Maahs, D. M., Jul 2008, In : Proteomics - Clinical Applications. 2, 7-8, p. 997-1007 11 p.

Urinary proteomics in diabetes and CKD

Rossing, K., Mischak, H., Dakna, M., Zürbig, P., Novak, J., Julian, B. A., Good, D. M., Coon, J. J., Tarnow, L., Rossing, P. & PREDICTIONS Network, Jul 2008, In : Journal of the American Society of Nephrology : JASN. 19, 7, p. 1283-90 8 p.

Long-term prevention of diabetic nephropathy: an audit

Schjoedt, K. J., Hansen, H. P., Tarnow, L., Rossing, P. & Parving, H-H., Jun 2008, In : Diabetologia. 51, 6, p. 956-61 6 p.

Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate

Astrup, A. S., Tarnow, L., Pietraszek, L., Schalkwijk, C. G., Stehouwer, C. D. A., Parving, H-H. & Rossing, P., Jun 2008, In : Diabetes Care. 31, 6, p. 1170-6 7 p.

Plasma connective tissue growth factor is an independent predictor of end-stage renal disease and mortality in type 1 diabetic nephropathy

Nguyen, T. Q., Tarnow, L., Jorsal, A., Oliver, N., Roestenberg, P., Ito, Y., Parving, H-H., Rossing, P., van Nieuwenhoven, F. A. & Goldschmeding, R., Jun 2008, In : Diabetes Care. 31, 6, p. 1177-82 6 p.

Time course of the antiproteinuric and antihypertensive effects of direct renin inhibition in type 2 diabetes

Persson, F., Rossing, P., Schjoedt, K. J., Juhl, T., Tarnow, L., Stehouwer, C. D. A., Schalkwijk, C., Boomsma, F., Frandsen, E. & Parving, H-H., Jun 2008, In : Kidney International. 73, 12, p. 1419-25 7 p.

ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy

Parving, H-H., de Zeeuw, D., Cooper, M. E., Remuzzi, G., Liu, N., Lunceford, J., Shahinfar, S., Wong, P. H., Lyle, P. A., Rossing, P. & Brenner, B. M., Apr 2008, In : Journal of the American Society of Nephrology : JASN. 19, 4, p. 771-9 9 p.

Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy

Lajer, M. S., Tarnow, L., Jorsal, A., Teerlink, T., Parving, H-H. & Rossing, P., Apr 2008, In : Diabetes Care. 31, 4, p. 747-52 6 p.

Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study

Lund, S. S., Tarnow, L., Astrup, A. S., Hovind, P., Jacobsen, P. K., Alibegovic, A. C., Parving, I., Pietraszek, L., Frandsen, M., Rossing, P., Parving, H-H. & Vaag, A. A., 2008, In : P L o S One. 3, 10, p. e3363

Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study

Persson, F., Rossing, P., Hovind, P., Stehouwer, C. D. A., Schalkwijk, C. G., Tarnow, L. & Parving, H-H., 2008, In : Scandinavian Journal of Clinical & Laboratory Investigation. 68, 8, p. 731-8 8 p.

Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study

Astrup, A. S., Nielsen, F. S., Rossing, P., Ali, S., Kastrup, J., Smidt, U. M. & Parving, H-H., Dec 2007, In : Journal of Hypertension. 25, 12, p. 2479-85 7 p.

Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy-a prospective follow--up study

Astrup, A. S., Tarnow, L., Christiansen, M., Hansen, P. R., Parving, H-H. & Rossing, P., Dec 2007, In : Diabetic Medicine. 24, 12, p. 1381-5 5 p.

Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history

Rossing, P., Dec 2006, In : Current Diabetes Reports. 6, 6, p. 479-83 5 p.

Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy

Persson, F., Rossing, P., Hovind, P., Stehouwer, C. D. A., Schalkwijk, C., Tarnow, L. & Parving, H-H., Dec 2006, In : Diabetes. 55, 12, p. 3550-5 6 p.

Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction?

Rossing, P., Parving, H-H. & de Zeeuw, D., Sep 2006, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 21, 9, p. 2354-7; discussion 2357-8

Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy

Schjoedt, K. J., Rossing, K., Juhl, T. R., Boomsma, F., Tarnow, L., Rossing, P. & Parving, H-H., Aug 2006, In : Kidney International. 70, 3, p. 536-42 7 p.

Impact of renin angiotensin system blockade on night to day blood pressure ratio in diabetic nephropathy

Jacobsen, P. K., Rossing, P. & Parving, H-H., Jul 2006, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 21, 7, p. 2030-1 2 p.

Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy

Rossing, P., Rossing, K., Gaede, P., Pedersen, O. & Parving, H-H., May 2006, In : Diabetes Care. 29, 5, p. 1024-30 7 p.

ACE-haemmere og AT-II-antagonister--beskytter de mod nyresygdom?

Rossing, P. & Parving, H-H., 10 Apr 2006, In : Ugeskrift for Laeger. 168, 15, p. 1564; author reply1564-5

Renoprotective effects of renin-angiotensin-system inhibitors

Parving, H-H. & Rossing, P., 18 Mar 2006, In : Lancet (London, England). 367, 9514, p. 898-9; author reply 900-2

Comparison of the effects of vitamins and/or mineral supplementation on glomerular and tubular dysfunction in type 2 diabetes

Rossing, P., Cooper, M. E. & Parving, H-H., Mar 2006, In : Diabetes Care. 29, 3, p. 747-8; author reply 748-9

Cardiac autonomic neuropathy predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy

Astrup, A. S., Tarnow, L., Rossing, P., Hansen, B. V., Hilsted, J. & Parving, H-H., Feb 2006, In : Diabetes Care. 29, 2, p. 334-9 6 p.

Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005

Rossing, P., Jan 2006, In : Diabetologia. 49, 1, p. 11-9 9 p.

Aldosterone synthase (CYP11B2)-344T/C polymorphism and renoprotective response to losartan treatment in diabetic nephropathy

Schjoedt, K. J., Lajer, M., Andersen, S., Tarnow, L., Rossing, P. & Parving, H-H., 2006, In : Scandinavian Journal of Clinical and Laboratory Investigation. 66, 3, p. 173-80 8 p.

Beneficial impact of spironolactone in diabetic nephropathy

Schjoedt, K. J., Rossing, K., Juhl, T. R., Boomsma, F., Rossing, P., Tarnow, L. & Parving, H-H., Dec 2005, In : Kidney International. 68, 6, p. 2829-36 8 p.

Progression of microalbuminuria in type 1 diabetes: ten-year prospective observational study

Rossing, P., Hougaard, P. & Parving, H-H., Oct 2005, In : Kidney International. 68, 4, p. 1446-50 5 p.

Improved prognosis in type 1 diabetic patients with nephropathy: a prospective follow-up study

Astrup, A. S., Tarnow, L., Rossing, P., Pietraszek, L., Riis Hansen, P. & Parving, H-H., Sep 2005, In : Kidney International. 68, 3, p. 1250-7 8 p.

Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy

Ahmed, S. B., Hovind, P., Parving, H-H., Rossing, P., Price, D. A., Laffel, L. M., Lansang, M. C., Stevanovic, R., Fisher, N. D. L. & Hollenberg, N. K., Aug 2005, In : Diabetes Care. 28, 8, p. 1988-94 7 p.

The changing epidemiology of diabetic microangiopathy in type 1 diabetes

Rossing, P., Aug 2005, In : Diabetologia. 48, 8, p. 1439-44 6 p.

Reduction of urinary connective tissue growth factor by Losartan in type 1 patients with diabetic nephropathy

Andersen, S., van Nieuwenhoven, F. A., Tarnow, L., Rossing, P., Rossing, K., Wieten, L., Goldschmeding, R. & Parving, H-H., Jun 2005, In : Kidney International. 67, 6, p. 2325-9 5 p.

Renoprotection with and without blood pressure reduction

Laverman, G. D., Andersen, S., Rossing, P., Navis, G., de Zeeuw, D. & Parving, H-H., Apr 2005, In : Kidney International, Supplement. 94, p. S54-9

Telmisartan vs. enalapril in type 2 diabetes

Parving, H-H., Hovind, P. & Rossing, P., 24 Feb 2005, In : The New England journal of medicine. 352, 8, p. 835-6; author reply 835-6

Risikofaktorer for udvikling af mikro- og makroalbuminuri ved type 1-diabetes: et incidenskohortestudie--en sekundaerpublikation

Hovind, P., Tarnow, L., Rossing, P., Jensen, B. R., Graae, M., Torp, I., Binder, C. & Parving, H-H., 2005, In : Ugeskrift for Laeger. 167, 1, p. 57-60 4 p.

Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate

Schjoedt, K. J., Andersen, S., Rossing, P., Tarnow, L. & Parving, H-H., Nov 2004, In : Diabetologia. 47, 11, p. 1936-9 4 p.

Angiotensin receptor blockers in diabetic nephropathy: renal and cardiovascular end points

Parving, H-H., Andersen, S., Jacobsen, P., Christensen, P. K., Rossing, K., Hovind, P., Rossing, P. & Tarnow, L., 2004, In : Seminars in Nephrology. 24, 2, p. 147-57 11 p.

Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy

Hovind, P., Tarnow, L., Rossing, P., Carstensen, B. & Parving, H-H., 2004, In : Kidney International. 66, 3, p. 1180-6 7 p.

Predictors for the development of microalbuminuria and macroalbuminuria in patients with type 1 diabetes: inception cohort study

Hovind, P., Tarnow, L., Rossing, P., Jensen, B. R., Graae, M., Torp, I., Binder, C. & Parving, H-H., 2004, In : BMJ. 328, 7448, p. 1105

Progression of nephropathy in type 2 diabetic patients

Rossing, K., Christensen, P. K., Hovind, P., Tarnow, L., Rossing, P. & Parving, H-H., 2004, In : Kidney International. 66, 4, p. 1596-605 10 p.

Birth weight--a risk factor for progression in diabetic nephropathy?

Jacobsen, P., Rossing, P., Tarnow, L., Hovind, P. & Parving, H-H., Mar 2003, In : Journal of Internal Medicine. 253, 3, p. 343-50 8 p.

Time course of the antiproteinuric and antihypertensive effect of losartan in diabetic nephropathy

Andersen, S., Jacobsen, P., Tarnow, L., Rossing, P., Juhl, T. R. & Parving, H-H., Feb 2003, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 18, 2, p. 293-7 5 p.

Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes

Hovind, P., Tarnow, L., Rossing, K., Rossing, P., Eising, S., Larsen, N., Binder, C. & Parving, H-H., 2003, In : Diabetes Care. 26, 4, p. 1258-64 7 p.

Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

Andersen, S., Tarnow, L., Cambien, F., Rossing, P., Juhl, T. R., Deinum, J. & Parving, H-H., 2003, In : Diabetes Care. 26, 5, p. 1501-6 6 p.

Smoking and progression of diabetic nephropathy in type 1 diabetes

Hovind, P., Rossing, P., Tarnow, L. & Parving, H-H., 2003, In : Diabetes Care. 26, 3, p. 911-6 6 p.

Optimal dose of losartan for renoprotection in diabetic nephropathy

Andersen, S., Rossing, P., Juhl, T. R., Deinum, J. & Parving, H-H., Aug 2002, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 17, 8, p. 1413-8 6 p.

Risk factors for development of incipient and overt diabetic nephropathy in type 1 diabetic patients: a 10-year prospective observational study

Rossing, P., Hougaard, P. & Parving, H-H., May 2002, In : Diabetes Care. 25, 5, p. 859-64 6 p.

Pregnancy and progression of diabetic nephropathy

Rossing, K., Jacobsen, P., Hommel, E., Mathiesen, E., Svenningsen, A., Rossing, P. & Parving, H-H., Jan 2002, In : Diabetologia. 45, 1, p. 36-41 6 p.

Renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?

Andersen, S., Tarnow, L., Cambien, F., Rossing, P., Juhl, T. R., Deinum, J. & Parving, H-H., 2002, In : Kidney International. 62, 1, p. 192-8 7 p.

Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1

Hovind, P., Tarnow, L., Rossing, P., Teerlink, T., Stehouwer, C. D., Emeis, J. J. & Parving, H. H., Dec 2001, In : American journal of kidney diseases : the official journal of the National Kidney Foundation. 38, 6, p. 1376-80 5 p.

Remission of nephrotic-range albuminuria in type 1 diabetic patients

Hovind, P., Rossing, P., Tarnow, L., Toft Sorensen, H., Parving, J. & Parving, H. H., Nov 2001, In : Diabetes Care. 24, 11, p. 1972-7 6 p.

Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively

Hovind, P., Rossing, P., Tarnow, L., Smidt, U. M. & Parving, H. H., Jul 2001, In : Kidney International. 60, 1, p. 277-83 7 p.

Attitudes towards diabetes and its care: Evaluation before, immediately post-course and ≥ 1 year after a practical, international inter-disciplinary course for diabetes teams

Rossing, P., Andersen, H., Hesselholdt, L., Thorsteinsson, B., Reimers, J., Binder, C., Nerup, J. & Mandrup-Poulsen, T., 24 Apr 2001, In : Practical Diabetes International. 18, 2, p. 39-44 6 p.

Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus

Rossing, P., Breum, L., Major-Pedersen, A., Sato, A., Winding, H., Pietersen, A., Kastrup, J. & Parving, H. H., Mar 2001, In : Diabetic Medicine. 18, 3, p. 199-205 7 p.

Progression of diabetic nephropathy

Hovind, P., Rossing, P., Tarnow, L., Smidt, U. M. & Parving, H. H., Feb 2001, In : Kidney International. 59, 2, p. 702-9 8 p.

Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes

Parving, H. H. & Rossing, P., Jan 2001, In : Diabetes Care. 24, 1, p. 177-80 4 p.

Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy

Myrup, B., Rossing, P., Jensen, T., Parving, H. H., Hølmer, G., Gram, J., Kluft, C. & Jespersen, J., 2001, In : Scandinavian Journal of Clinical and Laboratory Investigation. 61, 5, p. 349-56 8 p.

Preventing diabetic nephropathy: an audit

Hansen, H. P., Lund, S. S., Rossing, P., Tarnow, L., Nielsen, F. S., Jensen, T. & Parving, H. H., 2001, In : Scandinavian Journal of Clinical and Laboratory Investigation. 61, 6, p. 471-7 7 p.

Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy

Tarnow, L., Rossing, P., Jensen, C., Hansen, B. V. & Parving, H. H., Dec 2000, In : Diabetes Care. 23, 12, p. 1725-30 6 p.

Risikofaktorer for progression af diabetisk nefropati

Rossing, P., 18 Sep 2000, In : Ugeskrift for Laeger. 162, 38, p. 5057-61 5 p.

QTc interval length and QT dispersion as predictors of mortality in patients with non-insulin-dependent diabetes

Christensen, P. K., Gall, M. A., Major-Pedersen, A., Sato, A., Rossing, P., Breum, L., Pietersen, A., Kastrup, J. & Parving, H. H., Jul 2000, In : Scandinavian Journal of Clinical and Laboratory Investigation. 60, 4, p. 323-32 10 p.

Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy

Bos, H., Andersen, S., Rossing, P., De Zeeuw, D., Parving, H. H., De Jong, P. E. & Navis, G., Apr 2000, In : Kidney International, Supplement. 75, p. S32-7

Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy

Andersen, S., Tarnow, L., Rossing, P., Hansen, B. V. & Parving, H. H., Feb 2000, In : Kidney International. 57, 2, p. 601-6 6 p.

Cardiovascular morbidity and early mortality cluster in parents of type 1 diabetic patients with diabetic nephropathy

Tarnow, L., Rossing, P., Nielsen, F. S., Fagerudd, J. A., Poirier, O. & Parving, H. H., Jan 2000, In : Diabetes Care. 23, 1, p. 30-3 4 p.

Increased sympathetic activity during sleep and nocturnal hypertension in Type 2 diabetic patients with diabetic nephropathy

Nielsen, F. S., Hansen, H. P., Jacobsen, P., Rossing, P., Smidt, U. M., Christensen, N. J., Pevet, P., Vivien-Roels, B. & Parving, H. H., Jul 1999, In : Diabetic Medicine. 16, 7, p. 555-62 8 p.

Progression of diabetic nephropathy in normotensive type 1 diabetic patients

Jacobsen, P., Rossing, K., Tarnow, L., Rossing, P., Mallet, C., Poirier, O., Cambien, F. & Parving, H. H., Jul 1999, In : Kidney International, Supplement. 71, p. S101-5

Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy

Christensen, P. K., Rossing, P., Nielsen, F. S. & Parving, H. H., May 1999, In : Diabetic Medicine. 16, 5, p. 388-94 7 p.

Cyclosporine nephrotoxicity in type 1 diabetic patients. A 7-year follow-up study

Parving, H. H., Tarnow, L., Nielsen, F. S., Rossing, P., Mandrup-Poulsen, T., Osterby, R. & Nerup, J., Mar 1999, In : Diabetes Care. 22, 3, p. 478-83 6 p.

Effects of nisoldipine and lisinopril on left ventricular mass and function in diabetic nephropathy

Tarnow, L., Sato, A., Ali, S., Rossing, P., Nielsen, F. S. & Parving, H. H., Mar 1999, In : Diabetes Care. 22, 3, p. 491-4 4 p.

Concentration changes during venous occlusion of proteins with affinity for extracellular matrix in insulin-dependent diabetes mellitus A sign of vascular damage in patients with diabetic nephropathy?

Myrup, B., Rossing, P., Jensen, T., Gram, J., Kluft, C. & Jespersen, J., 1 Jan 1999, In : Fibrinolysis. 13, 3, p. 142-147 6 p.

Effects of nisoldipine and lisinopril on microvascular dysfunction in hypertensive Type I diabetes patients with nephropathy

Sørensen, V. B., Rossing, P., Tarnow, L., Parving, H., Nørgaard, T. & Kastrup, J., Dec 1998, In : Clinical science (London, England : 1979). 95, 6, p. 709-17 9 p.

Improved visual function in IDDM patients with unchanged cumulative incidence of sight-threatening diabetic retinopathy

Rossing, K., Jacobsen, P., Rossing, P., Lauritzen, E., Lund-Andersen, H. & Parving, H. H., Nov 1998, In : Diabetes Care. 21, 11, p. 2007-15 9 p.

Promotion, prediction and prevention of progression of nephropathy in type 1 diabetes mellitus

Rossing, P., Nov 1998, In : Diabetic Medicine. 15, 11, p. 900-19 20 p.

Diabetes and risk of adverse events with calcium antagonists

Parving, H. H. & Rossing, P., Oct 1998, In : Diabetes Care. 21, 10, p. 1779-80 2 p.

Promotion, prediction, and prevention of progression in diabetic nephropathy

Rossing, P., Sep 1998, In : Danish Medical Bulletin (Online). 45, 4, p. 354-69 16 p.

Betydningen af deletionspolymorfi i ACE-genet for progression af ACE-haemmerbehandlet diabetisk nyresygdom

Tarnow, L., Parving, H. H., Jacobsen, P., Rossing, P., Lecerf, L., Poirier, O. & Cambien, F., 17 Aug 1998, In : Ugeskrift for Laeger. 160, 34, p. 4886-9 4 p.

Assessment of glomerular filtration rate in diabetic nephropathy using the plasma clearance of 51Cr-EDTA

Hansen, H. P., Rossing, P., Mathiesen, E. R., Hommel, E., Smidt, U. M. & Parving, H. H., Aug 1998, In : Scandinavian Journal of Clinical and Laboratory Investigation. 58, 5, p. 405-13 9 p.

Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy

Jacobsen, P., Rossing, K., Rossing, P., Tarnow, L., Mallet, C., Poirier, O., Cambien, F. & Parving, H. H., Apr 1998, In : Kidney International. 53, 4, p. 1002-6 5 p.

Risikofaktorer for død hos insulinkraevende diabetikere

Rossing, P., Hougaard, P., Borch-Johnsen, K. & Parving, H. H., 23 Feb 1998, In : Ugeskrift for Laeger. 160, 9, p. 1315-9 5 p.

Doubling of serum creatinine: is it sensitive and relevant?

Rossing, P., Feb 1998, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 13, 2, p. 244-6 3 p.

Differences between the effect of nisoldipine and lisinopril on microvascular dysfunction in hypertensive IDDM patients with nephropathy

Sørensen, V. B., Rossing, P., Tarnow, L., Parving, H. H., Nørgaard, T. & Kastrup, J., 1 Dec 1997, In : Scandinavian Cardiovascular Journal, Supplement. 31, 45, 1 p.

Kidney function after withdrawal of long-term antihypertensive treatment in diabetic nephropathy

Hansen, H. P., Nielsen, F. S., Rossing, P., Jacobsen, P., Jensen, B. R. & Parving, H. H., Dec 1997, In : Kidney International, Supplement. 63, p. S49-53

Lisinopril improves endothelial dysfunction in hypertensive NIDDM subjects with diabetic nephropathy

Nielsen, F. S., Rossing, P., Gall, M. A., Smidt, U. M., Chen, J. W., Sato, A. & Parving, H. H., Aug 1997, In : Scandinavian Journal of Clinical and Laboratory Investigation. 57, 5, p. 427-34 8 p.

Left ventricular hypertrophy in non-insulin-dependent diabetic patients with and without diabetic nephropathy

Nielsen, F. S., Ali, S., Rossing, P., Bang, L. E., Svendsen, T. L., Gall, M. A., Smidt, U. M., Kastrup, J. & Parving, H. H., Jul 1997, In : Diabetic Medicine. 14, 7, p. 538-46 9 p.

Long-term effect of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy

Nielsen, F. S., Rossing, P., Gall, M. A., Skøtt, P., Smidt, U. M. & Parving, H. H., Jul 1997, In : Diabetes. 46, 7, p. 1182-8 7 p.

Polymorphisms in the interleukin-1 gene cluster do not contribute to the genetic susceptibility of diabetic nephropathy in Caucasian patients with IDDM

Tarnow, L., Pociot, F., Hansen, P. M., Rossing, P., Nielsen, F. S., Hansen, B. V. & Parving, H. H., Jun 1997, In : Diabetes. 46, 6, p. 1075-6 2 p.

Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment

Rossing, P., Tarnow, L., Boelskifte, S., Jensen, B. R., Nielsen, F. S. & Parving, H. H., Mar 1997, In : Diabetes. 46, 3, p. 481-7 7 p.

Renal protection in diabetes--an emerging role for calcium antagonists

Parving, H. H., Tarnow, L. & Rossing, P., 1997, In : Cardiology. 88 Suppl 3, p. 56-62 7 p.

Lav fødselsvaegt--øget risiko for diabetisk nefropati?

Rossing, P., Tarnow, L., Nielsen, F. S., Hansen, B. V., Brenner, B. M. & Parving, H. H., 30 Dec 1996, In : Ugeskrift for Laeger. 159, 1, p. 41-4 4 p.

Genetics of diabetic nephropathy

Parving, H. H., Tarnow, L. & Rossing, P., Dec 1996, In : Journal of the American Society of Nephrology : JASN. 7, 12, p. 2509-17 9 p.

Increased plasma apolipoprotein (a) levels in IDDM patients with diabetic nephropathy

Tarnow, L., Rossing, P., Nielsen, F. S., Hansen, B. V., Dyerberg, J. & Parving, H. H., Dec 1996, In : Diabetes Care. 19, 12, p. 1382-7 6 p.

Macro-microangiopathy and endothelial dysfunction in NIDDM patients with and without diabetic nephropathy

Parving, H. H., Nielsen, F. S., Bang, L. E., Smidt, U. M., Svendsen, T. L., Chen, J. W., Gall, M. A. & Rossing, P., Dec 1996, In : Diabetologia. 39, 12, p. 1590-7 8 p.

Fish oil in diabetic nephropathy

Rossing, P., Hansen, B. V., Nielsen, F. S., Myrup, B., Hølmer, G. & Parving, H. H., Nov 1996, In : Diabetes Care. 19, 11, p. 1214-9 6 p.

Renal protection in diabetes: an emerging role for calcium antagonists

Parving, H. H., Tarnow, L. & Rossing, P., Nov 1996, In : Journal of Hypertension, Supplement. 14, 4, p. S21-5

Diabetisk nefropati. Uaendret forekomst hos patienter med insulinkraevende diabetes mellitus

Rossing, P., Rossing, K., Jacobsen, P. & Parving, H. H., 14 Oct 1996, In : Ugeskrift for Laeger. 158, 42, p. 5940-3 4 p.

Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study

Rossing, P., Hougaard, P., Borch-Johnsen, K. & Parving, H. H., 28 Sep 1996, In : British Medical Journal. 313, 7060, p. 779-84 6 p.

Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study

Parving, H. H., Jacobsen, P., Tarnow, L., Rossing, P., Lecerf, L., Poirier, O. & Cambien, F., 7 Sep 1996, In : British Medical Journal. 313, 7057, p. 591-4 4 p.

Circadian rhythm of arterial blood pressure and albuminuria in diabetic nephropathy

Hansen, H. P., Rossing, P., Tarnow, L., Nielsen, F. S., Jensen, B. R. & Parving, H. H., Aug 1996, In : Kidney International. 50, 2, p. 579-85 7 p.

Angiotensin-II type 1 receptor gene polymorphism and diabetic microangiopathy

Tarnow, L., Cambien, F., Rossing, P., Nielsen, F. S., Hansen, B. V., Ricard, S., Poirer, O. & Parving, H. H., Jun 1996, In : Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 11, 6, p. 1019-23 5 p.

Benefits of long-term antihypertensive treatment on prognosis in diabetic nephropathy

Parving, H. H., Jacobsen, P., Rossing, K., Smidt, U. M., Hommel, E. & Rossing, P., Jun 1996, In : Kidney International. 49, 6, p. 1778-82 5 p.

Increased tissue factor pathway inhibitor activity in IDDM patients with nephropathy

Yokoyama, H., Myrup, B., Rossing, P. & Ostergaard, P. B., May 1996, In : Diabetes Care. 19, 5, p. 441-5 5 p.

Angiotensinogen gene polymorphisms in IDDM patients with diabetic nephropathy

Tarnow, L., Cambien, F., Rossing, P., Nielsen, F. S., Hansen, B. V., Ricard, S., Poirier, O. & Parving, H. H., Mar 1996, In : Diabetes. 45, 3, p. 367-369 3 p.

Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy

Myrup, B., de Maat, M., Rossing, P., Gram, J., Kluft, C. & Jespersen, J., 15 Feb 1996, In : Thrombosis Research. 81, 4, p. 485-90 6 p.

Fibrinolysis in insulin-dependent diabetic patients with and without nephropathy

Myrup, B., Rossing, P., Jensen, T., Gram, J., Kluft, C. & Jespersen, J., 1 Jan 1996, In : Fibrinolysis. 10, 5-6, p. 331-335 5 p.

Prevention and treatment of diabetic nephropathy with blood pressure lowering drugs

Parving, H. H., Rossing, P., Tarnow, L., Hommel, E. & Mathiesen, E., 1996, In : Nephrology. 2, p. 45-48

Correlation between microalbuminia and height

Rossing, P., 1 Dec 1995, In : Biomedicine and Pharmacotherapy. 49, 9, 1 p.

Low birth weight. A risk factor for development of diabetic nephropathy?

Rossing, P., Tarnow, L., Nielsen, F. S., Hansen, B. V., Brenner, B. M. & Parving, H. H., Dec 1995, In : Diabetes. 44, 12, p. 1405-7 3 p.

Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience

Parving, H. H., Rossing, P., Hommel, E. & Smidt, U. M., Jul 1995, In : American journal of kidney diseases : the official journal of the National Kidney Foundation. 26, 1, p. 99-107 9 p.

Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy

Tarnow, L., Cambien, F., Rossing, P., Nielsen, F. S., Hansen, B. V., Lecerf, L., Poirier, O., Danilov, S., Boelskifte, S. & Borch-Johnsen, K., Jul 1995, In : Diabetologia. 38, 7, p. 798-803 6 p.

On the mechanisms of blunted nocturnal decline in arterial blood pressure in NIDDM patients with diabetic nephropathy

Nielsen, F. S., Rossing, P., Bang, L. E., Svendsen, T. L., Gall, M. A., Smidt, U. M. & Parving, H. H., Jul 1995, In : Diabetes. 44, 7, p. 783-9 7 p.

Unchanged incidence of diabetic nephropathy in IDDM patients

Rossing, P., Rossing, K., Jacobsen, P. & Parving, H. H., Jul 1995, In : Diabetes. 44, 7, p. 739-43 5 p.

Increased glomerular filtration rate after withdrawal of long-term antihypertensive treatment in diabetic nephropathy

Hansen, H. P., Rossing, P., Tarnow, L., Nielsen, F. S., Jensen, B. R. & Parving, H. H., Jun 1995, In : Kidney International. 47, 6, p. 1726-31 6 p.

Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients

Tarnow, L., Cambien, F., Rossing, P., Nielsen, F. S., Hansen, B. V., Lecerf, L., Poirier, O., Danilov, S. & Parving, H. H., May 1995, In : Diabetes. 44, 5, p. 489-94 6 p.

Short stature and diabetic nephropathy

Rossing, P., Tarnow, L., Nielsen, F. S., Boelskifte, S., Brenner, B. M. & Parving, H. H., 4 Feb 1995, In : British Medical Journal. 310, 6975, p. 296-7 2 p.

Procoagulant activity and intimal dysfunction in IDDM

Myrup, B., Rossing, P., Jensen, T., Gram, J., Kluft, C. & Jespersen, J., Jan 1995, In : Diabetologia. 38, 1, p. 73-8 6 p.

Prevalence of arterial hypertension in diabetic patients before and after the JNC-V

Tarnow, L., Rossing, P., Gall, M-A., Nielsen, F. S. & Parving, H. H., Nov 1994, In : Diabetes Care. 17, 11, p. 1247-51 5 p.

Impact of lisinopril and atenolol on kidney function in hypertensive NIDDM subjects with diabetic nephropathy

Nielsen, F. S., Rossing, P., Gall, M. A., Skøtt, P., Smidt, U. M. & Parving, H. H., Sep 1994, In : Diabetes. 43, 9, p. 1108-13 6 p.

Monitoring kidney function in diabetic nephropathy

Rossing, P., Astrup, A. S., Smidt, U. M. & Parving, H. H., Jul 1994, In : Diabetologia. 37, 7, p. 708-12 5 p.

Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment

Rossing, P., Hommel, E., Smidt, U. M. & Parving, H. H., May 1994, In : Diabetologia. 37, 5, p. 511-6 6 p.

The use of antihypertensive agents in prevention and treatment of diabetic nephropathy

Parving, H. H. & Rossing, P., May 1994, In : Current opinion in nephrology and hypertension. 3, 3, p. 292-300 9 p.

Glomerular size- and charge selectivity in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy

Gall, M. A., Rossing, P., Kofoed-Enevoldsen, A., Nielsen, F. S. & Parving, H. H., Feb 1994, In : Diabetologia. 37, 2, p. 195-201 7 p.

Reduction in albuminuria predicts diminished progression in diabetic nephropathy

Rossing, P., Hommel, E., Smidt, U. M. & Parving, H. H., Feb 1994, In : Kidney International, Supplement. 45, p. S145-9

The effect of the relationship between tissue-type plasminogen activator and plasminogen activator inhibitor type 1 on tissue-type plasminogen activator activity in insulin-dependent diabetes mellitus

Myrup, B., Rossing, P., Jensen, T., Gram, J., Kluft, C. & Jespersen, J., 1 Jan 1994, In : Fibrinolysis and Proteolysis. 8, SUPPL. 2, p. 22-24 3 p.

Effective antihypertensive treatment postpones renal insufficiency in diabetic nephropathy

Parving, H. H., Smidt, U. M., Hommel, E., Mathiesen, E. R., Rossing, P., Nielsen, F. & Gall, M. A., Jul 1993, In : American journal of kidney diseases : the official journal of the National Kidney Foundation. 22, 1, p. 188-95 8 p.

Calcium antagonists and the diabetic hypertensive patient

Parving, H. H. & Rossing, P., Jun 1993, In : American journal of kidney diseases : the official journal of the National Kidney Foundation. 21, 6 Suppl 3, p. 47-52 6 p.

Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy

Nielsen, F. S., Voldsgaard, A. I., Gall, M. A., Rossing, P., Hommel, E., Andersen, P., Dyerberg, J. & Parving, H. H., May 1993, In : Diabetologia. 36, 5, p. 438-44 7 p.

Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients

Rossing, P., Hommel, E., Smidt, U. M. & Parving, H. H., May 1993, In : Diabetes. 42, 5, p. 715-9 5 p.

Effekten af captopril-, metoprolol- og hydroklortiazidbehandling hos ikke-insulinkraevende diabetikere (NIDDM) med primaer hypertension. En dobbeltblind, randomiseret overkrydsningsundersøgelse

Gall, M. A., Rossing, P., Skøtt, P., Hommel, E. E., Mathiesen, E. R., Gerdes, L. U., Lauritzen, M., Vølund, A., Faergeman, O. & Beck-Nielsen, H., 1 Mar 1993, In : Ugeskrift for Laeger. 155, 9, p. 636-41 6 p.

Apolipoprotein(a) in insulin-dependent diabetic patients with and without diabetic nephropathy

Gall, M. A., Rossing, P., Hommel, E., Voldsgaard, A. I., Andersen, P., Nielsen, F. S., Dyerberg, J. & Parving, H. H., Oct 1992, In : Scandinavian Journal of Clinical and Laboratory Investigation. 52, 6, p. 513-21 9 p.

Placebo-controlled comparison of captopril, metoprolol, and hydrochlorothiazide therapy in non-insulin-dependent diabetic patients with primary hypertension

Gall, M. A., Rossing, P., Skøtt, P., Hommel, E., Mathiesen, E. R., Gerdes, L. U., Lauritzen, M., Vølund, A., Faergeman, O. & Beck-Nielsen, H., May 1992, In : American Journal of Hypertension. 5, 5 Pt 1, p. 257-65 9 p.

Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy

Hommel, E., Andersen, P., Gall, M. A., Nielsen, F., Jensen, B., Rossing, P., Dyerberg, J. & Parving, H. H., May 1992, In : Diabetologia. 35, 5, p. 447-51 5 p.

3. Comparison of captopril, metoprolol and hydrochlorothiazide in hypertensive type-2 (non-insulin-dependent) diabetic patients

Rossing, P., Gall, M., Skott, P., Hommel, E., Mathiesen, E. R., Gerdes, U., Beck-Nielsen, H. & Parving, H. H., 1 Jan 1992, In : Journal of Hypertension. 10, 8, 1 p.

Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients

Gall, M. A., Rossing, P., Skøtt, P., Damsbo, P., Vaag, A., Bech, K., Dejgaard, A., Lauritzen, M., Lauritzen, E. & Hougaard, P., Sep 1991, In : Diabetologia. 34, 9, p. 655-61 7 p.

Red cell Na+/Li+ countertransport in non-insulin-dependent diabetics with diabetic nephropathy

Gall, M. A., Rossing, P., Jensen, J. S., Funder, J. & Parving, H. H., Jan 1991, In : Kidney International. 39, 1, p. 135-40 6 p.

Activities

Linking kidney and cardiovascular complications - impact on prognosis and treatment

Peter Rossing (Lecturer)
14 Dec 2019

Ecchocardiography in Diabetes and Heart Failure

Peter Rossing (Lecturer)
5 Dec 2019

Management of hyperglycemia in type 2 diabetes

Peter Rossing (Consultant)
5 Dec 2019

GLP 1 in diabetic kidney disease

Peter Rossing (Lecturer)
4 Dec 2019

Pathophysiology of diabetic kidney disease

Peter Rossing (Lecturer)
27 Nov 2019

EASD Scientist training course 2019

Peter Rossing (Organizer)
18 Nov 2019

KDIGO guideline on Diabetic Nephropathy

Peter Rossing (Lecturer)
17 Oct 2019

Diabetic Kidney Disease

Peter Rossing (Lecturer)
11 Oct 2019

Diabetic Nephropathy

Peter Rossing (Lecturer)
7 Oct 2019

Diabetic Nephropathy update

Peter Rossing (Lecturer)
21 Sep 2019

Metformin safety and efficacy in CKD

Peter Rossing (Lecturer)
19 Sep 2019

Proteomic prediction and renin angiotensin aldosterone system inhibition prevention of early diabetic nephropathy in type 2 diabetes with normoalbuminuria (PRIORITY) study

Peter Rossing (Lecturer)
19 Sep 2019

Mechanisms of Kidney Disease Progression: Understanding the role of inflammation and fibrosis

Peter Rossing (Lecturer)
16 Sep 2019

Steering group member

Peter Rossing (Consultant)
1 Aug 201931 Jan 2021

Diabetic kidney disease: Learnings so far

Peter Rossing (Lecturer)
14 Jun 2019

Edwin Bierman award: The link between the kidney and heart

Peter Rossing (Lecturer)
8 Jun 2019

Diabetic Kidney Disease

Peter Rossing (Lecturer)
26 Mar 2019

Sonar Study of Atrasentan in diabetic kidney disease

Peter Rossing (Lecturer)
13 Mar 2019

Guidelines for diabetes

Peter Rossing (Lecturer)
10 Mar 2019

New EASD ADA guidelines, and Nephroprotection with Type 2 DMtreatment

Peter Rossing (Lecturer)
27 Jan 2019

International Diabetes Federation 2019

Peter Rossing (Organizer)
1 Jan 20196 Dec 2019

steering group member

Peter Rossing (Consultant)
1 Jan 201931 Dec 2019

Myocardial Flow Reserve Assessed by Cardiac 82Rb PET/CT Is Associated with Albumin Excretion in Patients with Type 1 Diabetes

Emilie Hein Zobel (Lecturer), Signe Abitz Winther (Other), Bernt Johan von Scholten (Other), Lene Holmvang (Other), Andreas Kjær (Other), Peter Rossing (Other), Tine Willum Hansen (Other)
26 Oct 2018

EASD ADA guidline on treatment of hyperglycaemia in Type 2 Diabetes

Peter Rossing (Lecturer)
5 Oct 2018

Diabetes and Hypertension

Peter Rossing (Lecturer)
10 Aug 2018

Steering group member

Peter Rossing (Consultant)
1 Aug 201831 Jan 2021

ADA EASD position paper on treatment of hyperglycaemia in Type 2 Diabetes

Peter Rossing (Lecturer)
25 Jun 2018

Diabetes and Hypertension

Peter Rossing (Lecturer)
27 May 2018

Urine proteome - is there a role in predicting and monitoring diabetic nephropathy

Peter Rossing (Lecturer)
26 May 2018

New Treatments in Diabetic Kidney Disease

Peter Rossing (Lecturer)
24 May 2018

Prognosis and treatment of diabetic nephropathy :recent advances and perspectives

Peter Rossing (Lecturer)
22 Apr 2018

KDIGO guideline on Diabetic Kidney Disease

Peter Rossing (Consultant)
20 Jan 20181 May 2020

Steering group member

Peter Rossing (Consultant)
1 Jan 201831 Jan 2021

IDF Congress 2017

Allan Flyvbjerg (Participant), Peter Rossing (Participant), Ingrid Willaing (Participant), Tina Vilsbøll (Participant), Nana Folmann Hempler (Participant), Mette Andersen Nexø (Participant), Bryan Cleal (Participant)
4 Dec 20178 Dec 2017

ASN Kidney Week 2017

Peter Rossing (Participant), Marie Frimodt-Møller (Participant), Tine Wilum Hansen (Participant), Mie Klessen Eickhoff (Participant), Nete Tofte (Participant), Curovic Viktor Rotbain (Participant)
31 Oct 20175 Nov 2017

53rd Annual Meeting of the European Association for the study of Diabetes EASD

Allan Flyvbjerg (Participant), Birgitte Brock (Participant), Peter Rossing (Participant), Marit Eika Jørgensen (Participant), Susanne Engberg (Participant), Marie Frimodt-Møller (Participant), Narges Safai (Participant), Nete Tofte (Participant), Tina Vilsbøll (Participant), Viktor Rotbain Curovic (Participant), Bryan Cleal (Participant), Kasper Olesen (Participant)
11 Sep 201715 Sep 2017

American Diabetes Association’s 77th Scientific Sessions, ADA 2017

Allan Flyvbjerg (Participant), Peter Rossing (Participant), Birgitte Brock (Participant), Tommi Suvitaival (Participant)
9 Jun 201713 Jun 2017

30th Annual General Meeting of the European Diabetic Nephropathy Study Group, EDNSG

Peter Rossing (Participant)
19 May 201720 May 2017

Diabetic Nephropathy

Peter Rossing (Lecturer)
2017 → …

Treatment of Diabetes in CKD

Peter Rossing (Lecturer)
2017 → …

Prizes

Claus Bruun Honorary Lecture

Peter Rossing (Recipient), 2010

Dandy foundation honorary award

Peter Rossing (Recipient), 2000

Edward Bierman Award

Peter Rossing (Recipient), 9 Jun 2019

GOLGI prize

Peter Rossing (Recipient), 2016

Knud Lundbæk award

Peter Rossing (Recipient), 2017

Minkowski Prize

Peter Rossing (Recipient), 2005

Niels A Lassen prize

Peter Rossing (Recipient), 2015

Niels Schwartz-Sørensen Prize

Peter Rossing (Recipient), 2008

Novartis Young Investigator Award

Peter Rossing (Recipient), 2008

Professor Vishvanathans Honorary Award

Peter Rossing (Recipient), 2012

Ruth Østerby Honorary Award

Peter Rossing (Recipient), 2013

Projects

GALAXY - Gut-and-liver axis in alcoholic liver fibrosis

Rossing, P. & Trost, K.

01/01/201631/12/2021

Personalizing Treatment of Diabetic Nephropathy

Rossing, P.

01/06/201530/06/2021

Prevention of early renal function decline

Rossing, P.

20/12/201202/11/2019

PRIORITY: Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria.

Rossing, P., Persson, F. & Tofte, N.

02/01/201231/12/2018

ID: 50137657